intivo is used to treat the virus causing hepatitis c infection in adults and adolescents with chronic hepatitis c infecting adults and children from 1865 years of age . it is used in combination with peginterferon alfa , ribavirin and telaprevir , medicines called ns3 - 4a protease inhibitors . the ns3 -- 4a enzyme is a protein produced by the body that helps to fight hepatitis c virus . it can be taken with peinterferons alfa or ribavir . incivo is indicated for the treatment of adults with chronic chronic hepatitis b infection in patients who have previously been treated
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if you have been prescribed peginterferon alfa or ribavirin in addition to incivo . if you think any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor before taking incivo , peginerferon aluminiumfa or / or ribvirin . incivo should not be taken with the following medicines : - if you suffer from severe side effects 56 - if your doctor has prescribed the medicine alfuzos
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose regimen is one tablet once a day . the doctor will prescribe the recommended dosage regimen for you . the prescribed dose regimen for adults is 3 tablets once a week ( 6 tablets ) with 2 tablets once daily ( 8 tablets ) in the morning and evening . your doctor will determine the dose that is right for you and will prescribe it for you in accordance with the national recommendations for both hepatitis c virus infection and human immunodeficiency virus infection . efavirenz the recommendeddose regimen for
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : if you get an itchy skin rash , stop using incivo and seek medical help immediately . the rash may be severe . other symptoms of the rash include : a severe skin reaction . tell your doctor immediately if you have a skin rash . if your rash is severe , tell your physician . other signs of a rash include fever , tiredness , swelling of the face , swellingof lymph glands , a wide - spread rash , peeling skin , fever , flu - like symptoms , painful skin blisters , blisters in the mouth ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the exp date refers to the last day of that month . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do this after the bottle has been opened . do away with the bottle . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo delivers 375 mg telaprentir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
what zinbryta is zinbulta contains the active substance daclizumab beta , a monoclonal antibody . what zinbaq is used for zinbolta is used to treat multiple sclerosis in adults . it is used in combination with therapy ( two ms treatment ) or other treatments to reduce inflammation of the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms and repeated attacks ( relapses ). symptoms may occur when the nerves are damaged or if they do not work
do not take zinbryta if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor or pharmacist before taking zinryta : if you suffer from liver problems . your doctor may need to adjust your dose of zinibryta . if you are suffering from any other autoimmune disorders . if any of these apply to you , tell your doctor . if your doctor has told you to take any other medicines , including herbal supplements . if this applies to you ( or you are not sure
your doctor will decide how much zinbryta you need and how often you need to use this medicine . the recommended dose of zinbaq is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . the usual dose of your dose of the medicine is one tablet of zinfbaq once a week . your dose may be increased to 40 mg once this blood test is completed . your next dose may need to be delayed . your blood test will be repeated every three weeks . injecting yourself zinbuq is given under the skin ( subcut
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems : very common ( may affect more than 1 in 10 people ): unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin and whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may affects up to 1 in 100 people ): severe inflammation of the liver that may lead to death tell your liver
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . if you are not sure , talk to your pharmacist or nurse before using a new syringe / pen . do away with the syringes / pens that are no longer being used . store below 30
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml of solution for injection contains 150mg of dlizumb beta . 1ml of solutionfor injection contains sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zinbulryta with sodium '). what zinbaryta looks like and contents of the pack zin bryta is a clear to slightly yellow solution for injecting in a syringe / pen . it is
what wilzin is wilzin belongs to a group of medicines called metabolism products . what wilson ' s disease is wilson has a rare inherited defect in copper excretion from the liver to the eyes and brain . this result can lead to liver damage and neurological disorders . what is wiltin used for wilzin works by attaching to copper in the intestine and its further accumulation in the body . what are wilson s disease ? this treatment is used to treat wilson .
do not use wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using wilzin wilzin is used for initial therapy in adults with signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent called penicillamine . wilzin should be used during the initial treatment with other anti - copper agents such as penicillinamine . your doctor will monitor your symptoms closely during the treatment and will check your blood and urine regularly during treatment . sufficient
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the different dose regimens are listed below . the recommended dose is 25 mg / 50 mg twice a day . the dose is 1 mg wilzin 50 mg / 2 mg wilz 25 mg twice daily . the starting dose is one 25 mg capsule once a day ( 1 mg of wilzin ). the dose may be increased to 50 mg once a daily ( 2 mg of the medicine ). the starting dosage is one 50 mg capsule twice a morning ( 1 to 6 hours ) dose .
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported with wilzin : common ( affects 1 to 10 users in 100 ) uncommon ( affects less than 1 user in 1 , 000 ) rare ( affects more than 1 to 5 users in 10 , 000 ): very rare ( affect less than1 user in 10, 000 ) not known ( frequency cannot be estimated from the available data ): wilzin intake may cause gastric irritation during treatment . changes in blood tests , including an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells .
keep out of the reach and sight of children . do not store above 25 . do this after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicinal product does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of zinc acetate dihydrate ). each hard hard capsule of 50 mg of the active substances are zinc ( corresponding to 167 . 84 mg of of zin acetate dhydrate ), magnesium stearate . the capsule shell contains gelatin , titanium dioxide ( e171 ) and brilliant blue fcf ( e132 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white , oblong , biconvex , with wilzin 50 mg imprinted on one
biktarvy contains the active substance bictegravir . biktarv is an antiretroviral medicine ( also known as an integrase strand transfer inhibitor ). biktrelir is also known by its common name as emtricitabine . bictrelor is an antiviral medicine known as a nucleoside reverse transcriptase inhibitor ( nrti ). tenofovir alafenamide is an antitiretroviral medicine called a nucleotide reverse transcriptases inhibitor ( trti ) biktorvy is used for the treatment of human immunod
do not take biktarvy if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of these , tell your doctor . if you have taken any of any of your following medicines : - rifampicin used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ) a herbal remedy used to help you sleep and / or relieve depression and anxiety . warnings and precautions talk to your doctor before
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet a day . your doctor may also prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose should be adjusted by your doctor . your diet should be taken in combination with aluminium and magnesium hydroxide mineral supplements , vitamins , magnesium and iron ( see section 2 " biktarvy contains lactose "). your doctor will tell you how many tablets to take . if you take more bikarvy than
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : inflammation or infection in patients with advanced hiv infection ( opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation or previous infections may occur during hiv treatment . these symptoms are usually due to an improvement in the body ' s immune response and help fight infections . there are no obvious symptoms of autoimmune disorders . when a person is treated with medicines for hiv illness , autoimmune disorders may occur many months after treatment . tell the doctor immediately , if you notice
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains - the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktravir sodium equivalent to 50 mg bic tegravira , 200 mg emtracitabrine and ten ofovir aluminiumafenate fumarate equivalent to 25 mg tenofvir alufenamide - the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrog
novondorm is an oral antidiabetic medicine containing repaglinide , which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonorm is used to treat type 2 diabetic in adults . treatment is usually started with diet and exercise and weight reduction . your blood blood sugar may be increased when you start taking novonor or when metformin alone . if you have diabetes , novonors may
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonor ( listed in section 6 ). if you have type 1 diabetes . your doctor will check the acid level in your blood regularly . if you suffer from diabetic ketoacidosis . if your doctor has told you that you have a severe liver disease . if any of these apply to you , tell your doctor . if the doctor has also told you to take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 if you know that you suffer or have ever suffered from
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . you may take no vonorm with food or between 30 mg and 4 mg once daily . you should take no more than 30 mg once every 16 days . your doctor may increase your dose if your blood sugar is too high ( a hypo ). novonorg is not meant to be used to treat your diabetes . your treatment should be continued
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of hypoglycasemia is : common ( may affect up to 1 in 10 people ) a hypo in section 2 hypoglycemic reactions are generally mild / moderate . hypoemic unconsciousness may lead to coma . allergy allergy is rare ( may affects up to one in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating . anaphylactic reaction is a rare but serious reaction . other side effects are : common : may affect more
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ) ( 1 mg tablet only ) and iron oxide red ( e 172 ) ( 2 mg tablet ). what novonorg looks like and contents of the pack novonere tablets are white , round , flat , embossed with " pfizer
pumarix is a vaccine used in adults and adolescents ( aged 18 years and older ) to prevent pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens every 10 years . pandemic fluid is similar to ordinary flu but may be more serious . the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
do not use pumarix if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients of the vaccine ( see section 4 ). these ingredients are : egg , chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if you notice any of these , stop using the vaccine and seek medical treatment immediately . an allergic response to any ingredients of pumarax may occur . if this happens , stop having this
pumarix is for use in adults aged 18 years and older . pumarix contains a similar h5n1 as03 to those in the h5N1 vaccine . pumix is used in adults and adolescents aged 3 - 9 years and adolescents from 10 - 17 years . pumanix is not recommended for use by children younger than 18 years . your doctor will decide if pumarax is suitable for you . puminix is given as an injection into a muscle ( usually in the upper arm ). if you have any further questions on the use of this vaccine , ask your doctor or pharmacist .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure and shock . your doctor may need emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people redness or swelling where thejection is given fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to one in every 100 people ) bruising where the injections are given bruising a hard lump
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the suspension after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the suspension in the outer carton in order to protect from light . after the vaccine has been mixed , the vaccine should be used within 24 hours . do away with the suspension and throw away any unused suspension . do throw away medicines via wastewater or household waste . ask your pharmacist how to throw away medicine you no longer use .
what pumarix contains the active substance is split influenza virus ( 5 / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredients are haemagglutinin , which is present in the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvant contains squalene , dl - α - tocopherol , polysorbate 80 and adjuvants . the ingredients in the vaccine are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate , water for injections . what pumarax looks like and
what somakit t is somakiton t is a radiopharmaceutical product containing the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . the active ingredient is gallium (" 68ga ") edotreaotide . this procedure is performed by a doctor who is experienced in the use of gallium and edotrootide . it is injected into a vein or into the body areas . what somakt t is used for somakits t is for diagnostic use only . it should only be used in a medical imaging procedure called positron emission tomography (
do not take somakittoc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had allergic reaction to any of these ingredients ( listed under section 4 ). warnings and precautions talk to your doctor or pharmacist before taking somakttoc if : you have kidney or liver problems you have renal or hepatic disease you are under 18 years of age . you have dehydration . your doctor will decide whether the examination should be repeated 28 or whether you have other medical conditions that affect your body such as cushing syndrome , inflammation , thyroid disease , tumour
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc should only be used in special controlled areas . the use of somakitontoc 29 will be supervised by a specialist in the nuclear medicine field . the nuclear medicines specialist supervising the procedure will decide the quantity of somackittoc to be used . the usual dose is 100 mg or 200 mg megabecquerel per kg body weight . the quantity that will be used will depend on the type of medicine being used . somackiton t will be administered to you by a doctor or nurse who is experienced in
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with somakittoc : allergic reactions ( hypersensitivity ) have been reported with somackittoc . symptoms include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site due to ionising radiation , cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor or nuclear medicine nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials and radiolabelling . storage at the appropriate premises will be the responsibility and responsibility of specialist personnel . storage in the outer carton of somakittoc will be at a maximum of 4 to 25 g / m2 . do not use somakiton t if you notice any visible sign of deterioration of radioactive products . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg edotereotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid and sodium hydroxide and water for injections . - the solvent is sodium ( e421 ) and radiolabelling . - after reconstitution , the solution contains hydrochloric acid . what somakt t looks like and contents of the pack somakiton t is presented as a radiopharmaceutical preparation in a glass vial with black flip
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus stops the growth and spread of cancer cells . afinitor works by blocking the activity of a hormone receptor called hormone receptor - positive advanced breast cancer in postmenopausal women . it is used in combination with non - steroidal aromatase inhibitors to help keep the disease under control . it can also be used in addition to a medicine called exemestane ( a steroid inhibitor ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours that affect the stomach , bowels , lung or pancre
do not take afinitor if you are undergoing cancer treatment . warnings and precautions talk to your doctor or pharmacist before taking afinit if you : are allergic to everolimus , sirolimus , temsirolimu or any of the other ingredients of this medicine ( listed in section 6 ). are allergic if you think any of these apply to you , or if you have any problems with your liver . if you know that you have or have had any disease affecting your liver , tell your doctor . you may need a different dose of afininitor . if any of this applies to you ( or you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 10 mg of afinitor per day . if you have liver problems , your doctor may prescribe a lower dose of afginitor . the usual starting dose is 5 mg . your doctor will tell you how many tablets to take . the dose may be increased to 5 mg or 7 . 5 mg depending on certain side effects . if your doctor determines that the effect of afatinitor is too strong or too weak , your dose may need to be reduced . your dose will
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps . the following side effects have been reported with afincer : very common ( may affect more than 1 in 10 people ) - increased temperature ( chills ) - infection ) - fever - coughing - difficulty breathing - wheezing - inflammation of the lung ( pneumonitis 46 common ( might
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this by gently pushing the tablet down until it is completely dissolved . open the blister and discard the tablets . donot use this medication if you notice any visible sign of tampering . do so and return the tablet to your pharmacist . do away with the blister . do throw away any medicines via wastewater or household waste . ask your pharma how to throw away medicines you no
what afinitor contains - the active substance is everolimus . - afincer 2 . 5 mg : each tablet contains 2 . 75 mg of everolim . - the other ingredients are : - afinnitor 5 mg tablet : each tablets contains 5 mg of of everlimus . afiner 10 mg tablet: each tablet delivers 10 mg of either everolomimus or butylhydroxytoluene . - tablet coating : magnesium stearate , lactose monohydrate , hypromellose , crospovidone , lactos anhydrous . what afinitors looks like and
what laventair ellipta is lavent air ellipta contains two active substances called umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laventAIR ellipta looks like and contents of the pack laventive ellipta comes as a low - dose inhalation . it is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that occur when copd affects the muscles around the airways . this medicine works by tightening these muscles in the airway , making
do not use laventair ellipta 31 if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have asthma . warnings and risks talk to the doctor or nurse before using lavent air ellipta if you : have asthma , have heart problems , have high blood pressure , have an eye problem called narrow - angle glaucoma , have had an enlarged prostate , have difficulty passing urine , have a blockage in your bladder , have epilepsy , have
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours . do not use more laventair ellipta than your doctor tells you to . if you use more of lavent air ellipta , contact your doctor straight away . if symptoms of lavantair elliptka occur , you may experience a sudden attack of breathlessness or wheezing . if this attack occurs , you should have a quick - acting reliever inhaler ( such as
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop taking laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) and redness rare side effects : may affect 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ) feeling very wheezy or coughing , difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness immediate breathing difficulties immediate breathing difficulty stop taking this medicine and contact a doctor immediately
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umeklidinIUM ( equivalent to 65 microgram ) umelidinum bromate and 22 microgram s of vilanerol ( equivalent of trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose '), magnesium stearate what laventAir ellipta looks like and contents of the pack laventAIR ellipta is an inhal
what tremfya is tremfYA contains the active substance guselkumab , which is a monoclonal antibody . this medicine is a type of protein called il - 23 . what tremfia is used for tremfiya is used to treat adults with psoriasis . it is used in adults with moderate to severe " plaque psor psor " an inflammatory condition that affects the skin and nails . tremfyna works by helping improve the condition on the skin , and the appearance of nails . it helps reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using tremfia if you have an active infection or active tuberculosis warnings and risks talk to the doctor or nurse before using the vaccine if you : have an infection or an infection with tuberculosis 36 have an infected or have symptoms of an infection you are at risk of infections you have allergic reactions to tremfhey you should not receive a vaccination during treatment with
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . tremfya 100 mg ( 1 pre - filled syringe ) is given as an injection under the skin ( subcutaneous injection ). it may be given every 4 weeks or every 8 weeks . your doctor will decide how often you should receive your injection . if you have any further questions on the use of tremfYA , ask your doctor . if tremfia is not used in your country , ask you your doctor to ask you to return to your country . if not used
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not take this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre pre -filled syringe and allow it to reach room temperature ( up to 30 ) before use . do this medicine once it
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what tremfYA looks like and contents of the pack solution for injection in a vial is a clear , colourless to pale yellow solution . tremfia is supplied in a carton pack containing one single - dose glass syringe and a multipack containing 2 ( 2 packs of 1 )
the active substance of trepulmix is treprostinil . treprosteinil belongs to a group of medicines called prostacyclins ( a hormone that helps to control blood pressure ). by relaxing blood vessels , prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ). persistent or recurrent ctph is not treated with surgical treatment or exercise capacity . symptoms of the disease are similar to those of chronic thromeboembololic pulmonary hypotension . in patients with chronic throbembolic hypertension ,
do not take trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a disease called " pulmonary veno - occlusive disease ". this is a disease where the blood vessels in the lungs become swollen and there is a higher pressure in the blood arteries between the heart and the lungs . - if the child has severe liver disease . - tell your doctor if the patient has a heart problem . - have had a heart attack ( myocardial infarction ) in the last six months . - suffer from severe
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( subcutaneously ) under the skin through a small tube ( cannula ) in the abdomen or thigh . trepanmix is supplied in a pouch or a portable pump . you can take your treprostinil with or without food . the pump is connected to the infusion line and you can follow it for as long as your condition allows . the recommended dose is : accidental overdose ( 1 to 2 .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the infusion site bleeding or bruising at the injection site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in 100 people ): dizziness light - headedness fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgia ) swelling of feet , ankles , legs ( fluid retention ) hot flush pain in arms and / or legs 36 uncommon ( may effect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the trepulmix vial in the outer carton in order to protect from light . after reconstitution , trepulemix may be stored for up to 30 days at ambient room temperature ( 20 - 25 ) for continuous subcutaneous infusion in a single vial or a single reservoir ( syringe ) of undil
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treprostail ( as sodium salt ). each 10 ml vial delivers 10 mg trepristinill ( as water for injections ). each 2 . 5 ml vials delivers 2 . 75 mg trepistinila ( asodium salt ). every 10 ml ampial delivers 25 mg trepropstininil ( in sodium salt ) . trepiulmix 5 mg : every 5 ml ampreen delivers 5 mg trepromstinIL ( as salt ). the 10
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). the active substance in thorinanes is enocriptine . it works in two ways : 1 ) to prevent existing blood clots from forming and 2 ) to stop blood clotting in your blood . thorinne is used to prevent blood clumps from forming in your bloodstream . it can be used : - after an operation - to treat an acute illness called unstable angina ( a condition where your heart cannot pump blood properly ) - after a heart attack - to prevent the formation
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ), tell your doctor straight away . if a reaction occurs , you may experience a severe drop in the number of your clotting cells ( platelets ). this reaction
like other similar medicines ( medicines to prevent blood clotting ), thorinane is used to prevent bleeding . the bleeding should be stopped immediately . if you experience any bleeding event that does not stop immediately , you should contact your doctor immediately . your doctor may decide to temporarily or permanently stop your medicine . if any of the above apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking thorinan . if a severe allergic reaction occurs ( difficulty breathing , swelling of the lips , mouth , throat or eyes ), blockage of a blood vessel or a blood clot , cramping pain , redness ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiratory date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice any particles in the solution or if the thorinane pre - filled syringes are damaged . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains - the active substance is enoxaparin sodium . each ml of solution contains 100 mg of enoxagarin sodium ( as monohydrate ). each pre - filled syringe contains 0 . 2 ml of enxaparin ( as halofilate ). - the other ingredients are water for injections ( 0 . 5 ml of concentrate ) and solvent for injections . what thorinanes looks like and contents of the pack thorinan is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield with chlorobutyl rubber stopper and a blue polypropylene plun
sensend contains the active substances lidocaine and prilocaine , as local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , which allows ejaculation to last longer .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). if you have a history of allergy or sensitivity to local anaesthetics ( amide - type local anaesthesia ). if your doctor has told you that you have or have had a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ) or anaemia ( methaemoglobinaemia ). if any of these apply to you , tell your doctor . medicine sensitivities and sensitivity are not normally associated with severe liver problems . if
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 ml ( 3 . 5 ml ) once a day . 1 ml is injected into the head of your penis . 3 ml is given every 24 hours for up to 4 weeks . the spray container is then placed in the pump mechanism . the valve is closed to avoid contact with eyes , nose , mouth and ears . the pump is then used to remove 1 ml from the foreskin of your head . 1ml is injected in
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very common ( may affect more than 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may affects up to 1 in 100 people ) headache local irritation of the throat , irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the penis pain or discomfort in the place of the penises itching in the space of the area around the penis a high temperature other side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the label after exp . the exp date refers to the last day of that month . store below 25 and use within 12 hours . do away with the metal container after first opening . donot puncture or burn the container . do this after the end of the first use . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilucaine . one spray container contains 50 ml of lidocane and 7 . 5 ml of prilacaine . - each spray container provides 2 . 5 mg of prlocaine per ml . - the other ingredients are : each spraycontainer contains 6 . 5 to 20 ml of spray . - one spraycontainer provides 5 to 12 ml of light yellow cutaneous spray . what senstends looks like and contents of the pack senstension is a
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma is advanced and cannot be removed by complete resection in adults ( treatment with surgery or adjuvant therapy ). advanced non - small cell lung cancer is a type or form of lung cancer in adults advanced renal cell carcinoma is a form of advanced kidney cancer in adult and in adults classical hodgkin lymphoma has not been previously treated with previous therapies , including an autologous stem - cell transplant or a transplant . advanced cancer of the head and neck is a kind or form in adultsadvanced uro
do not take opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking opdivone if you : - have problems with your heart , such as a change in the rhythm or a change of the heartbeat . - have an abnormal heart rhythm . - develop problems with one or more of your lungs , such breathing difficulties or cough . - inflammation of the lungs ( pneumonitis or interstitial lung disease ). - have diarrhoea , watery , loose or soft stools . - if
always take opdivo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of opdivone is 240 mg twice a day ( 2 tablets ) for up to 480 mg twice daily ( 4 tablets ). your doctor will prescribe the strength that is right for you . your doctor may also prescribe ipilimumab for the treatment of skin cancer . the dose of the combination of op divo with 1 mg of nivolumab is based on kilogram of your body weight . the daily dose is 4 tablets of opilimumabe . the weekly dose is
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . store below 25 and refrigerate for 48 hours . do away with the infusion solution and any unused medicine . any unused product or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg nivlumab ( as 40 mg / ml ). each 4 ml vial contains 100 mg nlumb ( as 240 mg / l ). each 24 ml vials contains 240 mg nnlumba ( as 300 mg / s ). - the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opdivos contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide ,
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrel tetad is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( a condition which can lead to stroke , heart attack ,
do not take clopidogrel tad 30 - if you are allergic to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking clopridogrelTad . warnings and precautions talk to you doctor or nurse before taking any of your medicines : - if : you have an increased risk of bleeding
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , which is based on your condition and ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally once a day , with or without food . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl to be given orally once at the start of each course of treatment . your doctor will then decide how many
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), which may cause bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an allergic
what clopidogrel tad contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 in the film - coating . what clopidiogrel tetad looks like and contents
tacforius contains the active substance tacrolimus , which is an immunosuppressant . tacforius is used after your organ transplant to protect your liver and kidney from the effects of your body ' s immune system . tacfortius is also used to prevent your body from rejecting transplanted organs . tacfius is given to prevent rejection of transplanted organ by your liver , kidney , heart or any previous treatment you were taking at the time of your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been given sirolimus , any macrolide ( antibiotic ) such as erythromycin , clarithromycin or josamycin . tacrolamus immediate release capsules ( e . g . tacni ) tacforia prolonged - release capsules are not available in the following pack sizes : tacrolemus immediate - release capsule and tacforus prolonged -release capsules
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine is for oral use only . transplant patients should take the same tacrolimus medicine as adults . if you have had a transplant with a different tacrolelimus medicines , your doctor may prescribe this medicine . always take this medication exactly as described in this leaflet . check the box at the end of this leafle for information about how to take tacforius . if your doctor thinks that the right medicine is not suitable for you , talk to your doctor . the dose you take will
like all medicines , this medicine can cause side effects , although not everybody gets them . infections can be serious and you must stop taking tacforius and tell your doctor immediately if you notice any of the following serious or severe effects : allergic and anaphylactic reactions ( benign or malignant tumours ) have been reported during tacforia treatment . pure red cell aplasia ( a very severe reduction in red blood cell counts ) and agranulocytosis ( a severely lowered number of white blood cells ) have also been reported . haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . discard 1 capsule after opening the aluminium wrapping . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforus 0 . 5 mg : each hard capsule contains 0 . 25 mg of tacrolamus ( as monohydrate ). tacforia 1 mg : one hard capsule each contains 1 mg of ticrolimas ( asohydrate ). each capsule each hard hard capsule also contains tacrolemus (as monohydrate ) . tacfortius 3 mg : three hard capsules each contain 3 mg of of tacrulimus ( monohydrate ), respectively . tacofius 5 mg and 5 mg hard capsules also contain 5 mg of the active ingredient tacro
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidiogrelzentiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( a condition which can lead to stroke , heart
do not take clopidogrel zentiva - if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking clopridogrel . warnings and precautions talk to you doctor or nurse before taking any of your medicines : - if : you have an increased risk
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day with food . if you have a condition called ' atrial fibrillation ' ( an irregular heartbeat ), your doctor may prescribe a lower dose of 75 mg of clopidogrel zentiva ( two tablets at once ) to be taken once a week . if severe chest pain ( unstable angina or heart attack ) has been experienced , your doctor will prescribe 300 mg of the same strength of clubidogl zent
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), which may cause bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an allergic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . clopidogrel zentiva may be stored in aluminium blisters for up to 30 days . do this when you are not using clopridogrelzentiva in all aluminium blacks . do away with this medicine if you notice any visible sign
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopidoogrel ( as hydrogen sulphate ). see section 2 ' clopydogrelzentiva contain lactose ' and ' clapidogl zentva contains hydrogenated castor oil '. the other ingredients are mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e464 ),
yttriga is a radioactive medicine that must not be used after the expiry date which is stated on the label and carton after exp . the expiratory date refers to the last day of that month . yttrigba is stored in a refrigerator ( 2 - 8 ). it is stored at ambient temperature ( up to 25 ) in a separate unit . it must not freeze . ytriga must not use in combination with another medicine . tiny radiation doses are used for the treatment of radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - you must not be pregnant or breast - feeding if you think you may be pregnant . warnings and precautions talk to your nuclear medicine doctor before using yttrada - yttrida is a radioactive medicine . it is not a radiopharmaceutical . - ytriga contains radioactive material . radioactive medicinal products are stored in the outer layer of the nuclear medicine facility ( the outer layers of the outer wall of the vial ). see section 2 for information about radioactive medicinal product
yttriga will be administered to you by a doctor experienced in the treatment of radiolabelling of medicinal products . the doctor will determine the appropriate dosage for you and will determine if yttrigba is suitable for you . the treatment will be supervised by a physician experienced in radiolamination of medicinal product for specific diseases . if you are given more yttiga than you should in case of overdose , your doctor will decide whether appropriate treatment is needed .
like all medicines , yttriga can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises and under local regulations . storage of radioactive substances will be in accordance with national regulation on radioactive materials .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg hydrochloric acid ( equivalent to 3 mg ). - the vial is a v - capped bottom in a colourless type i glass vial of 10 ml with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains the active substance cisplatin , another anti - cancer medicine . it is used for treatment of malignant pleural mesothelioma , a form of cancer that affects the lining of the lung that has not responded to prior chemotherapy . cimbra is also used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . how ciamba works lung cancer is a type of lung disease that develops slowly after treatment has stopped . it can be treated with either initial chemotherapy or ciambrex as a
do not use ciambra if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciamba ( listed in section 6 ). if you have breast - feeding during treatment with ciamb . if you think you may be allergic , ask your doctor for advice . if any of these apply to you , tell your doctor before using ciambro . if your doctor has recently given you a vaccine against yellow fever , tell the doctor before you are given ciambre . if this applies to you ( or you are not sure ), tell your physician before you receive ciamBra . if
the recommended dose of ciambra is 500 mg for every square metre of your body ' s surface area . this means that your height and weight are measured in square meters ( m² ) of body surface area each day . your doctor will work out the right dose for you based on this body surfacearea . your dose and duration of treatment will depend on your blood cell counts and on your general condition . your healthcare professional will have mixed the ciamra powder with 9 ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamba will be given to your doctor by infusion into one of your
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience fever or infection with a temperature greater than 38ºc or greater , sweating , or any signs of infection . if you have less white blood cells than normal which may indicate infection ( sepsis ), which may lead to death . if this happens , tell your physician straight away . if chest pain ( with a fast heart rate ), pain , redness , swelling or sores in your mouth are signs of allergic reaction . if any of the above apply to you , tell the doctor straight away and tell them
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . do away with the reconstituted solution . the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 7 , 8 - 15 and
what ciambra contains - the active substance is pemetrexed . each vial of ciamba 100 mg contains 100 mg pemetreed ( as pemetereed disodium hemipentahydrate ). each vials of cembra 500 mg contains 500 mg pemrexed (as pemetereted dis sodium hemipontahydrates ). after reconstitution , the solution contains 25 mg petrexed per ml of solution . further dilution by a healthcare professional is required . - the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) which help to control certain infections in your blood . immunogam is used to prevent increased levels of human hepatitis b immunoglubulins and immunoglofulin g ( ig ) in the blood plasma of screened adults . immunoglogam can be used in adults . your doctor will test for the presence of immunogogam in the body and will determine whether immunogams is suitable for you . immunogenam is indicated for the treatment of hepatitis b virus in haemodialysed patients . vaccination with a hepatitis
immunogam should not be used if you have an allergic reaction to human immunoglobulins or other blood products . if you suffer from an iga deficiency , an allergic response may occur to iga containing products . children and adolescents immunogam is not recommended for use in children and teenagers under 18 years of age . immunoglubulins are not recommended in this age group . signs of adverse reactions include chills , headache , fever and vomiting . allergic reactions may include nausea ( arthralgia ), joint pain and low blood pressure . moderate low back pain may be the signs of antibodies . if your
munogam is intended for vaccination of hepatitis b virus . the first vaccine dose will be given in combination with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose of hepatitis c is 500 micrograms per kg body weight every 24 hours for 72 days . the recommended recommended dose for hepatitis b in haemodialysed patients is 500 mgrams ( kg ) per kg of body weight each 2 weeks . seroconversion is recommended . vaccination with hepatitis b is usually given by a hepatitis birus carrier . the hepatitis b antigen should be prepared by a healthcare professional prior to seroconverting
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported with immunogams : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) rare ( affects less than 1 users in 1 , 000 ) very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) very common : may affect more than one in 10 , 000 patients not known : frequency cannot estimate from the reported data undesirable effects during clinical trials with immunogenam in the muscle common : affects
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . donot use immunOGam if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogaman 1 mg / ml solution for injection contains 5 mg of human plasma protein ( antigen ) 96 % ( expressed in units ) polysorbate 80 . what immunogams looks like and contents of the pack immunogamer is a solution forjection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . it comes in packs of 1 vial and 1 vials .
remicade contains the active substance infliximab . inflixumab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnf ). remicade belongs to a group of medicines called ' tnsf blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew ' s disease ) psoriasis . remicades is used in adults , adolescents and children aged 6 years and older with crohn '
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to tb if you have another serious infection , such as pneumonia , sepsis or heart failure if you know that you may have been given remicADE . if you do not respond to remicad , tell your doctor or pharmacist . warnings and precautions talk to your doctor before taking remicada . if any of these apply to you , tell the doctor or nurse before taking the medicine . if your doctor
treatment in adults with rheumatoid arthritis the recommended dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases the recommended starting dose is 5 mg for each kg of the body weight , given once a week . how remicade is given remicine will be given to you by your doctor or nurse as an infusion ( drip ) over 2 hours into one of your veins ( usually in your arm ). the third treatment will be administered by your
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . if you notice any of the following side effects during your treatment with remicade , stop taking remicades and contact your doctor immediately : - an allergic reaction ( swelling of your face , lips , mouth or throat , difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles ). these reactions are rare but if you have an allergic response , contact your physician immediately . see section 2 for more information . allergic side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . remicade may be used for infusion , up to 3 days at 2 to 8 , or for up to 28 days at 25 . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 25 unless the solution is clear
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixamab . after reconstitution , each ml contains 10 mg of infiximb . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicada is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to off - white . remicaded is available in packs of 1 , 2 , 3 , 4 and 5
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson '. in parkinson ', s disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body that is important for movement control . rasagilinea mylan increases the amount of dopamine produced in the blood and helps to maintain a balance between movements and movement . raspagilmine mylan also increases the levels of dopamine in your brain .
do not take rasagiline mylan - if you are allergic to rasagailine or any of the other ingredients of this medicine ( listed in section 6 ). - if severe liver problems . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease . it is also used in combination with medicinal or natural products ( such as st . john ' s wort or pethidine ) as a strong pain killer . see section 14 for further information . during r
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day . take the tablet at about the same time each day . you can take it with or without food . you should take the tablets at about 1 hour before or with food . take them by mouth . you may take rasagiline mylan with or just after food . if you take more rasgiline melan than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show the rasaga my
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with rasagiline mylan and placebo : frequency not known : side effects reported with the following frequencies : common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to 1 users in 1 , 000 ) very rare ( affects less than 1 users of 10 , 000 ). very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina p
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains rasigiline tartrate equivalent to 1 mg rasgailine - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch and talc , stearic acid . what rasaggiline melan looks like and contents of the pack rasagleiline tablets are 11 . 5 mm x 6 mm , biconvex tablets debossed with " r " on one side and " 1 " on the other side
do not use hulio if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe infection , such as tuberculosis . if you experience symptoms of infections such as fever , wounds , feeling tired , dental problems . if your child has moderate or severe heart failure . if any of these apply to you , tell your doctor . allergic reaction allergic reactions may include symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . if these reactions occur , tell the doctor immediately . infections tell your child ' s doctor if you get
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . polyarticular juvenile idiopathic arthritis ( in adults ) in adults and adolescents from 2 to 17 years old : the usual dose is 10 mg once a day . this is increased to 30 mg once daily . hulio is 20 mg once every 2 weeks . in children from 2 - 17 years of age : the standard dose is 30 mg twice a day ( 1 tablet of hulia per day ). this is also increased to 40 mg once weekly . enthesitis
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and may require urgent medical treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 of this leaflet ): - after the last hulio injection - allergic reaction ( e . g . heart failure ) - severe rash , hives swollen face , hands or feet - trouble breathing or swallowing - pale complexion - dizziness - persistent fever , bruising or bleeding - signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hullio looks like and contents of the pack hulios 40 mg is a sterile solution for injection ( injection ) containing 40 mg of adalimimumab in 0 . 8 ml of solution . the solution is clear to slightly opalescent and has a rubber stopper . hulIO is available in packs containing 1 , 2 or 1 syringe , 1 sterile
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ) which reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is worsening . - if skin allergy ( intense inflammation in your nose ). - when you are using other nsaids ( such as acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine may be used in combination with topical steroids ( such such as cortisone ). - unwanted side effects - if there have been bleeding problems in patients with haemophilia in the past . - in
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of yellox is one drop in the eye ( s ) twice a day . the recommended daily dose is one dose in the morning and one dose of one drop of the eye in the evening . the daily dose may be increased or decreased depending on your cataract surgery . method of administration yellox is for oral use . wash your hands before using the eye drops . remove the bottle cap from the bottle . hold the bottle tightly closed with
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers called opioids . sufENTanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzuvoo if : you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). dzuuveo may affect your breathing during treatment . you have had a head injury or brain tumour . you suffer from problems with your heart and circulation such as slow heart rate or irregular heartbeat . you experience low blood
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the single - dose administration device is for single use only . you should swallow the tablet whole with water . do not chew or crush the tablet . you can take this tablet with or without food . dzuveo must be taken with strong painkillers such as sufentanil 30 mg twice a day . the sublingual tablet must be swallowed whole with a glass of water . the disposable single -dose applicator should be used immediately after taking the tablet , so that
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : severe breathing problems , slow and shallow breathing . if you get any of these side effects stop taking dzuveo and contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick and feeling hot . common side side effect ( may effect up to 1 in every 10 people ) : inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drows
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use this product if you notice any visible sign of deterioration . do this if you are a pharmacist or nurse . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg suffentenil ( as citrate ). - the other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine ( e132 ), stearic acid and magnesium stearate . what dzuvoo looks like and contents of the pack dzuvello is a white to off - white , round tablets with " d " debossed on one side and " 3 " debottled on the other
elleada is a cancer medicine containing apalutamide that is used to treat prostate cancer that has spread to other parts of the body and cannot be removed by surgical treatments . it is used in adult patients with sensitive prostate cancer which has spread beyond the original part of the prostate and cannot receive surgical treatment . it works by reducing the levels of testosterone in the blood . it also reduces the amount of androgens produced by prostate cancer . it can also reduce the amount androgens released by prostate cancers . apalutaamide stops the production of androgen , which can kill prostate cancer cells .
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if pregnant or think you may be pregnant ( see section " pregnancy , breast - feeding and contraception section "). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine is not recommended if you have had seizures . - if any of these apply to you ( or you are not sure ), talk to a doctor or nurse before taking erleade . - tell your doctor if you take any medicines that could increase the risk of blood clots (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how well you respond to erleada . take this medication by mouth . you can take erleade with or without food . other medicines and erlead tell your doctor if you take , have recently taken or might take any other medicines . if you forget to take erelada if you miss a dose , take it as soon as you remember . if it is almost time for your
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling and ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis is a group of serious side effects . the following side effects are listed below : fits ( seizure ) uncommon ( may affect up to 1 in
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apaluamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine celluloise . - in the film - coating : iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide . what erlead looks like and contents of
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used for scan - related diagnostic use ( a pet scan ) in adults who have previously had treatment for prostate cancer . it can be used in combination with other tests to determine prostate specific antigen ( psa ) and the cancer that has spread . an axumin pet scan is used to determine whether the cancer has spread to other organs . the scan will be done in a hospital setting . axum is used in adults whose doctor has considered that the clinical benefit of the product outweighs the risk of radiation .
do not use axumin if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . if you have kidney problems . if your doctor has told you to follow a low sodium diet . axumin is given once a day for the duration of the axumin scan ( see section 4 for further information ). during the scan , you will be given your usual medicines to take at the latest 60 minutes . you may also be given a lower dose ( one tablet of 60 mg ) after the axul injection
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin must only be used in special controlled areas . this medicine is for diagnostic use only . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used . the usual dose is 370 megabecquerel per kilogram of body weight . axon must not be used if you are not sure . the procedure axumin is injected into a vein by a flush of sodium chloride solution . the doctor supervises the procedure . the duration of the procedure is one hour . the scan will last approximately 5 minutes
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( affects more than 1 user in 100 ) the medicine was used to reduce the number of side effects that were seen after axumin was used . uncommon ( affects 1 to 100 users in 1 , 000 ) the following were reported after axon was used : pain , rash , altered taste in the mouth , altered sense of smell . this radiopharmaceutical emits low amounts of ionising radiation which may increase the risk of cancer and hereditary abnormalities . reporting of side effect if you get
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : axumin will be stored in accordancewith national regulation .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each tablet contains 1600 mg fluciniclovine ( as as as 16000 mg ). axumin 3200 mg : one tablet contains 3200mg flucucicline ( 3200 / 32000 mg ) - the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin is sodium "). what axumin looks like and contents of the pack white to off - white , round , flat , bevelled tablet with " tmc " debossed
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to reduce high pressure in the eye , which can lead to an illness called glaucoma . lowering the pressure in your eye reduces the damage to your sight .
do not take azopt if you have severe kidney problems if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking azopt . the same allergy may be associated with too much acidity in your blood ( hyperchloraemic acidosis ). if any of these apply to you , tell your doctor before taking this medicine . if you do not have
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used in both eyes . use azopt in both of your eyes . 1 drop in each eye . use in both the eyes : use azop in both both eyes : 1 drop , 2 drops , 3 drops . hold the azopt bottle tightly closed with your hands . remove the cap . remove it from the bottle . hold it firmly , pointing down . tilt the cap back . snap collar . hold down the bottle with a clean finger and squeeze . pull down a ' pocket ' between the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects include : bad taste . uncommon side effects - effects affecting up to1 in 100 people ) ( effects in both eyes : sensitivity to light , inflammation , infection of the conjunctiva , eye swelling , eyelid itching , red , swelling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to protect from infections , a pack containing a single bottle should be used immediately .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brin zolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide ( for acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack containing
what forxiga is forxigo contains dapagliflozin . it belongs to a group of medicines called medicines taken by mouth to treat diabetes . it works by helping control the level of sugar in your blood . what forxige is used for adults and adolescents aged 18 years and older , forxig is used to treat a type of diabetes called type 1 diabetes that affects one part of your body ( the pancreas ) and cannot be controlled with any insulin . forxinge is used in adults to treat type 1 , in which you are overweight or obese . type 2 diabetes is when your body does not
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if feeling sick or being sick ( stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness ), a sweet smell to your breath , a sweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid weight loss . contact your doctor immediately if you experience any of any of these or any combination of the above symptoms
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for type 2 diabetes is one tablet a day . your doctor may increase your dose to 10 tablets a day ( 5 mg ) if you have a liver problem . your dose of the tablet may be adjusted . your usual dose of both forxige and type 1 diabetes is two tablets a morning and one tablet in the evening ( 5 hours apart ). your doctor will tell you how many tablets to take . taking this medicine swallow the tablet whole with some water . forxig
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are angioedema ( seen in more than 1 in 10 , 000 people ). angioEDema may cause swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( seen with more than one in 10 people ) is a type of diabetes that develops in adulthood . it can occur in up to 1 in every 10 people . if you have type 2 diabetes , it can happen in up in every 1 , 000 to 1 , 600 people . diabeticketo
what forxiga contains - the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapapagllozin propanediol monohydrate equivalent to 5 mg dapablifloin . - the other ingredients are microcrystalline cellulose , lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone , silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol 3350 , yellow iron oxide ( e172 ). what
mifamurtide is a medicine that blocks the activity of certain bacteria in the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults aged between 2 and 30 years . it is used when surgery is not possible to remove the tumour and chemotherapy is not able to stop cancer cells from growing . it also helps to prevent cancer from coming back .
do not take mepact if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). if you have taken medicines containing ciclosporin or other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ) or nsaids . if you think any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking mepactor : if you : have problems with your heart or blood vessels such as blood clots ( thrombosis ), bleeding ( haemorrhage ), inflammation of the veins
treatment mepact will be given to you by a doctor or nurse . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much mepat to use the recommended dose is 2 mg mifamurtide per kilogram body weight every 12 hours for 24 hours . your doctor will decide how many of your mepacts treatments you need and will adjust your chemotherapy schedule . your chemotherapy will be repeated every 36 hours . how to use treatment mepACT is given to your doctor by a qualified healthcare professional . you will be monitored by a healthcare professional
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients treated with mepacts ( transient use of paracetamol ). if you experience fever during treatment with mepanact , tell your doctor immediately . if you have continuing fever and chills within 8 hours of taking mepACT , tell the doctor immediately and seek medical advice . if any of the above applies to you , tell a doctor or nurse straight away . if your doctor thinks you may have an infection , such as rash , tell them immediately . any problems breathing or wheez
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . keep the vial in outer carton in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 30 ) for up to 6 months . do this medicine if you notice any visible sign of deterioration . do throw away any medicines via wastewater or household waste . ask your pharmacist
what mepact contains - the active substance is mifamurtide . each vial contains 4 mg mifamanurtide ( as suspension ). after reconstitution , each ml of suspension contains 0 . 08 mg mufamurtime . - the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine ( see section 2 under ' mepacts contains lactose '), 2 - dileoyls - sn - glyco - 5 - phospho - l - serine monosodium salt ( see also section 2 "
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin and face to reduce redness ( rosacea ) and redness of the face . rosica is a condition of high levels of blood flow in theacial skin that results in enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels , thus reducing the excess blood flow and reding of the surface .
do not take mirvaso if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). if you take the medicine under the skin ( see section " warnings and precautions "). warnings and risks mirvasos may interact with certain medicines used to treat depression or parkinson ' s disease ( monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine ), tetracyclic antidepressant such as maprotiline or mians
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin or face . this medicine is applied on the surface of your body . the surface area of your skin covers your eyes , mouth , nose or vagina . do not use mirvasos if you notice any change in the appearance of your eyes . if you use more mirvasoe mirvasoa is applied onto the face once a day . the treatment is usually started with a small amount of gel ( a pea - sized amount ). if your symptoms do not improve after
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain , discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects ( may affect up to 1 in 10 people ): worsening of rosacea , which may occur during the treatment . symptoms may occur within 2 hours of contact allergy . allergic reaction may include rash and rare angioedema . if you have a serious allergic reaction , including swelling mainly of the face , mouth and tongue , stop taking mirvaso
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the tube and pumping in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonate tartrate . - the other ingredients are : carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasoa contains methylparasahydroxybenzoates "), propyleneglycol . what mirvasos looks like and contents of the pack
mvasi contains the active substance bevacizumab , a humanised monoclonal antibody ( a type of protein that is made by the immune system to help defend the body from infection and cancer ). bevacsizumb binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found in lymph vessels all over the body . the vegfs protein is found on blood vessels that carry blood and oxygen . bevocizumib slows tumour growth and allows blood vessels to expand , thus increasing the nutrients and oxygen in the blood . mvasi is used
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products if you or your child are pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . mvasic may increase the risk of developing holes in the gut wall ( inflammation inside the abdomen ) if your or your baby ' s doctor has told you that you have diverticulitis ( stomach ulcers
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer you have . the usual dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight , given once every 15 days . your doctor may increase your dose depending on your general condition and on your size of tumour growing . the recommended dose of this medicine is one mvasu vial per kg body weight . you will be given mvasis every 2 or 3 weeks . your number of infusions will depend on how you respond to treatment with this medicine .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : side effects that may occur during treatment with mvai or after chemotherapy . these side effects are usually mild to moderate and usually disappear after a few days . if they occur during the first few days after receiving mvasic , tell your doctor straight away . allergic reactions if you have an allergic reaction , you may experience difficulty in breathing , chest pain , redness or flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in the outercarton in order to protect from light . infusion solutions may be stored for up to 24 hours at 2 to 8 or at room temperature ( up to 30 ). the infusion solutions should be used immediately after dilution in a sterile environment . do away with the valsi if you
what mvasi contains - the active substance is bevacizumab . each ml contains 25 mg of bevocizumb in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active ingredient bevaconizumumab in 1. 4 ml of water . each 16 ml vials contains 400 mg of of bebacizumaab in 16 .5 ml of solvent . - the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in adults , adolescents and children who are not able to take other medicines . tecartus can be used : to treat refractory mantle cell lipoma in adults : - when your own white blood cells are no longer viable ( autologous anti - cd19 - transfduced cd3 + cells ). mantle cell lungoma is a cancer that affects the immune system ( the body ' s natural defences ) that affects b - lymphocytes . mantle cell oligoma affects b lymphocytes in an uncontrolled way . teCartus works by
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using tecartuse if you : - have had a decrease in the number of white blood cells in your blood ( lymphodepleting chemotherapy ) ( see section 3 ) - have a decrease of the number white blood cell in your body ( autologous use ) - had tests or checks of your lungs , heart , kidney or blood pressure - have any signs of infection
what tecartus is tecartuse is made from your own white blood cells . your cells will be given to you by a doctor or nurse through a catheter placed in your vein ( a procedure call leukapheresis ). your white blood will be collected from your blood and given to your doctor or hospital . tecartuses is given to patients who have already received a dose of 3 or 6 doses of your whiteblood cells . it is given every 2 weeks for up to 3 months . medicines given before tecartust treatment ( lymphodepleting chemotherapy ) the modified white blood cell will be injected into your body
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you . if you notice any of the following side effects you may need urgent medical attention : the following serious side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure with symptoms such as dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness , decreased level of consciousness and confusion , memory loss ). disturbances of brain function
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after reconstitution , the product is stable for up to one hour in a single infusion bag . the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would
what tecartus contains - the active substance is autologous anti - cd19 - transduced cd3+ cells . each single infusion bag contains a dispersion of anti -cd19 car t cells ( equivalent to 68 x 2 cd3 + cells ). - the other ingredients are : 106 anti - dna , sodium chloride , human albumin ( see section 2 " tecartu contains sodium "). what tecartub looks like and contents of the pack tecartucus is a clear , colourless solution for infusion . it is supplied in an infusion bag with a metal cassette . a single infusionbag contains 68
januvia contains the active substance sitagliptin and belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which are used to control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . this helps to lower your blood sugar when you have your type 2abetes . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas or glitazones ) that lower blood
do not take januvia if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). if you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi if you : have had blistering of the skin ( bullous pemphigoid ). januvin may cause a disease of the pancreatreas called pancreatitis ( gallstones ). have alcohol dependence . have very high levels of triglycerides in your blood . you have any of these medical conditions . if you think any of this applies
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 mg taken by mouth once daily . if you have kidney problems , your doctor may increase your dose to 25 mg or 50 mg once daily depending on how you respond to this medicine . this medicine should be taken with or without food . this is because it may affect the way januvia works . your doctor will tell you if you need to take certain other medicines to control blood sugar . if your doctor determines that the effect of januvi is
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact your doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ) which may reach through to your back , nausea and vomiting ( signs of an inflamed pancreas ( pancreatitis ). these may be signs of a serious allergic reaction ( frequency not known ): rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . stop using this medicine
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . - in addition , the tablet film - coating contains poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what januves looks like and contents
what xultophy is xultue is a type of insulin that helps control blood glucose . it is used to treat type 2 diabetes mellitus in adults . diabetes is a problem where your body does not produce enough insulin . the insulin that your body produces does not work as well as it should . this results in a high level of blood sugar . insulin degludec is a long - acting basal insulin that is used in adults to control your blood sugar levels . liraglutide ( a type in glp - 1 ) is a substitute for insulin during meals . what xultose is used for xult
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). if you have 39 a sulfonylurea , glimepiride or glibenclamide . your sulfonylation dose should be increased every three weeks . your blood sugar levels should be monitored while you are taking xulto . if you suffer from type 1 diabetes mellitus or ' ketoacidosis ' ( a condition that occurs when your blood sugars are too high ). warnings and precautions talk to your doctor or pharmacist
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your blood sugar level . the recommended dose of xultophy is 41 mg once a day . you should use xultue every day for 8 days . do not take xultose if you feel that the effect of xulophy is too strong or too weak . xultide is supplied in a pre - filled dial - a - dose pen . the dose counter is shown on the pen
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out or become unconscious . serious hypoglycaemia ( may cause brain damage ) can occur . if you have low blood sugars , your blood glucose level may be too low ( hypoglycasemia is a common symptom of this section ). serious allergic reaction ( anaphylactic reaction ) ( frequency not known ) if you experience a serious allergic reactions , you should contact your doctor immediately . if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening : store in the original package in order to protect from light . after opening : do not store above 30 . store at room temperature ( up to 8 ) for up to 21 days . do away with the cap and the bottle after this period . do throw away any medicines via wastewater or household waste . ask your pharmacist
what xultophy contains - the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin degluudec 3 . 6 mg liragolutime in 3 ml solution . each vial contains 300 units of the active substance insulin deglbudec 10 . 8 mg liraagluteide in 3ml solution . - the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xultphil contains sodium "). what
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 ] and her2 [ erbb2 ] ( erbb3 ]). these proteins are involved in the growth of cancer cells . this medicine stops these proteins from growing and kills cancer cells , so this medicine can be used to treat cancer of the lung ( non - small cell lung cancer ). giotriff is used for your first treatment after prior chemotherapy treatment in squamous type a when prior chemotherapy therapy treatment has not worked .
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( less than 50 kg ) if your doctor has told you that you have kidney problems if you think you have one of the following side effects : lung inflammation ( interstitial lung disease ) if any of these apply to you , tell your doctor . liver problems your doctor may need to change your dose or stop some liver tests while you are taking this medicine . if you suffer from a severe liver disease . eye problems if any one of these applies to you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take this dose with or with food . you may take this this medicine with or just after food . take this picture with a mirror . you will find it easier to see what you have taken . the tablet can be divided into two equal doses . take the tablet at
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment with giotrinif : diarrhoea common ( may affect up to 1 in 10 people ): diarrhoeas ( see section 2 under ' warnings and precautions ') severe diarrhoehoea with fluid loss common ( might affect up in 1 in every 10 people ) low blood potassium ( worsening kidney function ) if you experience diarrhoee after diarrhoeing , contact your doctor immediately . appropriate antidiarrhoeal treatment should be started in combination with antidiarhoeal medicine prior
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinab . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections . what giotratif looks like and contents of the pack giotarif 20 mg film - coating tablets are white , round , biconvex , with " gsi
what orkambi is orkamsi contains two active substances called lumacaftor and ivacaftOR . what orkami is used for orkammi is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older with a mutation called f508del mutation . f508d is a protein that is found in cystic Fibrosis transmembrane conductance regulator ( cftr ) in the lungs . the mutation causes an abnormal cftl protein . how orkmbi works lumacftor and / or ivacft
do not take orkambi if you are allergic to lumacaftor or ivacaftour or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have been told that the f508del mutation is present in orkababab , tell your doctor . if any of these apply to you , tell the doctor or nurse before taking this medicine . children and adolescents do not give this medicine to children under 6 years of age because the dose of orkaban is not known . if your child has been
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 6 tablets a day . your doctor will tell you how many tablets to take . the usual dose is one tablet a day for 12 weeks . your orkambi tablet should be taken every day for 6 weeks . the dose may be adjusted by your doctor . the maximum recommended dose for 11 weeks is one orkammi 100 mg tablet a 2nd day . the 2nd and 3rd day are for 12 years . your dose may also be adjusted with orkababab
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects listed below have been observed with orkambi and ivacaftor . if any of the above apply to you , tell your doctor or pharmacist before taking orkammi . serious side effects that may occur with orkyambi include raised levels of liver enzymes in the blood , liver injury , pre - existing severe liver disease , and the worsening of liver function . the following side effects have been reported with orksambi : uncommon ( may affect up to 1 in 100 people ): pain or discomfort in the upper
what orkambi contains the active substances are lumacaftor and ivacafton . orkammi 100 mg film - coated tablets each tablet contains either 125 mg lumacftor and 125 mg ivacfton . each tablet of orkmbi 200 mg film- coated tablets one tablet contains 125 mg of lumacaptor and 150 mg iviacaftor . each tablets of orkyambi 100mg film - coating contains either 200 mg of or kambi 200mg film- coating contains : cellulose , microcrystalline , croscarmellose sodium , hypromellose
what lynparza is lynparanza contains the active substance olaparib . olaparateib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ) that works by preventing mutations ( changes ) in a gene called brca ( breast cancer gene ). in cancer , parp inhibitors cause death . how lynparz works olaparaib works by blocking the activity of an enzyme called ' parp ' that helps repair dna . what lynparZA is used for lynparzar is used to treat adult patients with ovarian cancer
do not use lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). if you have been told by your doctor that you have an increased risk of developing a reaction to lynparz . warnings and precautions talk to your doctor or pharmacist before using lynparze if you : have low blood cell counts ( shown in testing ) low counts of red or white blood cells ( shown as low platelet counts ) see section 4 possible side effects 75 the signs and symptoms of fever , infection , bruising , bleeding and more serious problems with the bone marrow ( known
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg or 150 mg . the doses of lynarza capsules are taken in combination with tablets . if you take more than a capsule of lynarcza daily , you may experience side effects . the usual dose is 8 mg of lynpalza taken by mouth once in the evening . if possible take the tablet with food . if necessary take the tablets with a glass of water . if not , take the next dose at the usual time . if more than
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may affects up to 1 in 100 people ): allergic reactions ( hives , difficulty breathing , swallowing , dizziness ). signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect up to1 in 10 , 000 people : feeling sick ( nausea ) being sick ( vomiting )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store any lynparza capsules in the original package in order to protect from light . after first opening , lynparZA capsules may be stored at room temperature ( up to 30 ) for a maximum period of 3 days . if you notice any capsules are damaged , discard the capsules . do away with the capsules and throw them away . do this
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg olaparateib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack lynparZA is a white , opaque , hard capsule with " olaparatib 50 mg " imprinted on the cap and " astrazeneca logo on the body . lynparanza is available in packs containing 112
this medicine contains the active substance naloxone . nalxone is used to treat opioid addicts who have been treated with heroin , methadone , fentanyl , oxycodone , buprenorphine or morphine . nyxoid is also used as a nasal spray for the emergency treatment of opioid overdose in adults . opioid overdose is a serious , life - threatening , and can be fatal in up to 14 cases . overdose may lead to breathing problems and severe sleepiness . if you have an opioid overdose , you should be aware that opioids may be present in your blood and you should immediately contact your doctor or emergency medical
do not use nyxoid if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). if you think this applies to you , tell your doctor or pharmacist before using this medicine . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . warnings and precautions talk to your doctor before using nyxoids , pharma or nurse before using it . if an opioid overdose occurs , tell the doctor or nurse straight away . the signs and symptoms of an opioid dose may be similar to those of an overdose . if this nasal
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one spray . 1 . use the spray as soon as possible . symptoms should be : shoulders , ears , breastbone , sternum , ear , fingernail . 2 . clear the mouth and nose of any blockers . breathe in through the mouth or nose . 1 ). breathe in using a deep breath . breathe out through the chest . breathe through the nose . 2 ). breathe out slowly . 3 . if you have any problems with breathing , such as the chest moving ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms from opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawalsymptoms may affect up to 1 in 100 people . these symptoms are : common (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone ( as hydrochloride dihydrate ). - the other ingredients are trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . - the concentration of ndaloxone in 0 . 1 ml is defined as the amount of nloxone per dose . what nyxoids looks like and contents of the pack nyxoidal is a clear , colourless to pale yellow solution for injection in a pre - filled nasal spray
what ovaleap is ovaleep contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). fsh is involved in the growth and development of the sacs ( follicles ) in the ovaries . it is involved for the production of sperm and in the development of a immature egg cell . treatment with a medicine called " clomifene citrate " is used in assisted reproductive technology procedures ( procedures to help you become pregnant ) and in adult women . it can be used in combination with a medication called " lutrop
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland , which is located in the brain . if you think you may have large ovaries or sacs of fluids in your ovaries . if your ovary does not produce enough ovarian cysts . if unexplained vaginal bleeding . if any of these apply to you . if there is cancer in your ovarian , womb or breasts . if if you suffer from any condition that makes normal
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use this medicinal product is for injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , you should inject this medicine every day for the first 7 days of your menstrual cycle . you should continue to inject the medicine until your doctor tells you otherwise . the usual dose of this medicine is 75 mg once a day . this medicine can be used for the 7 days ( corresponding to 37 . 5 mg ) of each 75 mg dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 common ( may affect up to 1 in 10 , 000 people ) type of reaction your ovaleop injection should be stopped immediately . serious sideeffects in women lower stomach ache and nausea and vomiting . the symptoms may be due to ovarian hyper - stimulation syndrome ( ohss ). the ovaries
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a maximum of 3 days at room temperature ( up to 25 ). do this medicine if it is stored for more than 3 days in the refrigerator ( up or down ) at room temperatures ( up and down ) or at room room
what ovaleap contains the active substance is follitropin alfa . ovaleep 300 iu / 0 . 5 ml : each cartridge contains 300 iiu ( 22 micrograms ) follitroin ala in 0 . 05 ml . ovalesap 450 iu : each cartridges contains 450 iiu / 0. 75 ml . each cartridge also contains 33 microgram ( 23 microgram ) follitonropin alpha in 0.75 ml . what ovaleop looks like and contents of the pack ovaleaps 900 iu per 1 . 5 mm : each carton contains 900 iiu of foll
voriconazole accord contains the active substance voriconazol . voronazole is an antifungal medicine that works by killing the fungi that cause infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp ). candidaemia ( a form of fun fungal illness caused by candida sp ). in non - neutropenic patients ( abnormally low white blood cells count ) to treat candida Sp . infections . the active ingredient in voricoazole can be flu
do not take voriconazole accord - if you are allergic to voricazole or any of the other ingredients of this medicine ( listed in section 6 ). - if any of these apply to you . - if your child is taking any other medicines , including herbal medicines . the medicines listed below are not recommended during voricoazole accord treatment . 46 terfenadine ( for allergy ) astemizole ( for allergic ) cisapride ( for stomach problems ) pimozide ( for mental illness ) quinidine ( for irregular heart beat ) rifampicin ( for tuberculosis )
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual starting dose is 40 mg twice a day . this will be increased to 40 mg once a day for 24 hours . your dose will be gradually increased to 400 mg once daily for 12 hours . this may be increased every 12 hours for 24 to 24 hours or to 200 mg once every 100 hours . depending on how you respond to treatment , your doctor may increase your dose to 300 mg once weekly . if
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . serious side effects of voriconazole accord include rash and jaundice ( changes in blood tests of liver function ) and pancreatitis . other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual
what voriconazole accord contains - the active substance is voricazole . each tablet contains 50 mg vorinazole ( as monohydrate ). - voricoazole accord 50 mg film - coated tablets : each tablet has 200 mg vorbiconazose ( as biconohydrate ). the other ingredients of voricleazole acord 200 mg are lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactosemonohydrate and triacetin
mvabea is a vaccine used to protect against ebola virus disease in the future . adults and children from 1 year of age and older who have ebola virus , a 2 - dose course of vaccinations , will be given to protect them against ebolas virus disease caused by the zaire ebolavirus or filovirus . this vaccine contains the whole ebolairus , which is responsible for giving you ebola viral disease . vaccinations are given with zabdeno vaccine 8 weeks later . mvabeas vaccine is not recommended for you ebolas virus disease is caused by ebola . as with all
your doctor will decide on the vaccination course . the vaccine should not be given if you have a severe allergic reaction ( see section 6 . if you think you may have asevere allergic reaction , ask your doctor for advice ). if you are given an antibiotic called ' gentamicin ' ( see ' other medicines and mvabea '). if you receive mvagaa if you had a severe allergy reaction to any other vaccine injection . if any of the following apply to you , tell your doctor before you receive the vaccine . if your doctor thinks you may be at an increased risk of having a severe reaction , tell the doctor
the recommended dose of vaccine is given by injection into a muscle ( intramuscular injection ) in the upper arm or thigh or into a blood vessel . the recommended dose is one dose of one dose ( 0 . 5 ml ) of vaccine . the second dose ( 1 . 5ml ) of zabdeno vaccine will be given 8 weeks later . if you are given more mvabea vaccine than you should if you have received more mbq than you were told to , your doctor will give you the second vaccine . if any of the above applies to you ( or you are not sure ), talk to your doctor
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth , swelling where the injection is given very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) feeling sick ( vomiting ) itching where the vaccine is given uncommon ( may affects up to one in every 100 people ): redness , skin hardness where the needle is given generalised itching . the most common side effects are : common ( likely to affect up in every 1 in 100 people
what mvabea contains the active substance is zaire ebolavirus 29 ( tai forest ebolovirus nucleoprotein marburg ) in 0 . 7 ml of solution . the other ingredients are : 108 micrograms of the active substances are chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections and hydrochloric acid ( for ph adjustment ). what mvafaa looks like and contents of the pack mvagaa is a suspension for injection in a single - dose glass vial with a rubber stopper
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ) and other bone problems that may need surgery or radiotherapy bondronAT can be used if you have a raised calcium level in your blood or if you are at risk of developing a tumour . this means that the calcium is lost from your bones . this may also mean that your bones are weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronAT if you : have a side effect called osteonecrosis of the jaw ( onj ) this can lead to bone damage in the jaw . your doctor may decide to stop treatment with bondronatin if you suffer from cancer or related conditions . onj can be life - threatening and may be life threatening . stopping treatment with onj may be a
this medicine is given to you by a doctor or nurse who is experienced in the treatment of cancer . it is given as an infusion into your vein . your doctor will carry out regular blood tests to check how well you are being treated with bondronat . your dose of this medicine depends on your illness . if you have breast cancer that has spread to your bones , it may take 3 - 4 weeks before you receive an infusion in your vein , which may take up to 15 minutes . if there is a raised calcium level in your blood , it can be given as a single dose of 1 mg or 2 mg every 2 weeks .
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . unusual fracture of the thigh bone . rare ( might affect up in up to one in 10 , 000 patients ) pain or sore in your mouth or jaw . severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone . ear pain or discharge from the ear . these may be signs of an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). after dilution the infusion solution should be used within 24 hours . do this medicine if you notice particles in it or if the solution is discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bondronat contains - the active substance is ibandronic acid . each vial contains 2 mg ibandorid in a concentrate for solution for infusion . each ml contains 2mg ibandronat . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack the concentrate for bondronate is a clear , colourless to pale yellow solution . it is supplied in a glass vial with a bromobutyl rubber stopper .
what zeposia is zeposeia is a medicine that belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ). what zepOSia is used for zepoesia is given to adults with relapsing remitting multiple sclerosis ( rrms ) as an active disease . what is multiple sclerosis ? multiple sclerosis is a disease in which the body ' s immune system ( the body '' s defences ) does not work properly . white blood cell ( s ) are important as they help to protect the nerves of the brain and spinal cord . they also help to defend the nerves .
do not take zeposia if you are allergic to zanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack , angina , stroke , mini - stroke or transient ischemic attack ( tia ). if severe heart failure has occurred within the last 6 months . if your heartbeats ( arrhythmia ) are irregular or abnormal heartbeaters ( arrrhythmia ). if your doctor thinks that your heart is not working properly after treatment . if any of these apply to you , tell your doctor .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need and will work on your heart rate . your doctor may prescribe you a ' treatment initiation pack ' with a lower dose . the first 4 days of treatment are 0 . 23 mg ozanimod per day . this will be given to you in a ' dose - dependent ' condition . this is followed by 1 to 4 days ' rest period . the second 4 days ( rest period ) are 0. 46 mg ozim
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( blood pressure uncommon ( may affects up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : side effects that may be serious include : common ( might affect up to1 in 10 , 000 people ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) and voice box
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any damage to the pack or if the blister is damaged . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains - the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zepoesia 0. 46 mg : one capsule contains approximately 0 . 46 mg ozimod ( as hydrated hydrochlorides ). ziposia 0 , 92 mg : two capsules contain approximately 0. 92 mg ozmod (as hydrated hydrated ) ozanimood ( ashydrated hydrate ). - the other ingredients are : capsule shell : 0 . 03 mg : gelatin , titanium dioxide ( e171
the active substances of temybric ellipta are fluticasone furoate , umeclidinium bromide and vilanterol . fluticasmone furate belongs to a group of medicines called corticosteroids ( steroids ). umecylidinIUM bromine and vilterol belong to a class of medicines known as bronchodilators . what temybrexta is used for temybrric elliptic is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties . in
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using temy bric ellipte - if your child has asthma . temybinric elliptoe should not be used in children with asthma . - if the child has heart problems , high blood pressure , liver problems , tuberculosis ( tb ) of the lung , or any long standing or untreated infections . - tell your doctor if
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours . do not take temybric ellipta more than once a week . if you use more temybi than you should if you have used more tembric ellipta than you have been told to , contact your doctor straight away . symptoms of temybubric elliptka may include a sudden attack of breathlessness or wheezing . if this attack occurs ,
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse while taking this medicine , tell your doctor straight away . pneumonia ( infection of the lung ) ( copd ) the most common side effect of temybric ellipta is symptoms of a lung infection such as fever and chills . increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) are sore , raised patches in the mouth or throat . this may be a fungal infection ( candid
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms flutic asone firoate , 65 microgram of umeklidinIUM bromate , 55 microgram s umelidinum and 22 microgramS vilansterol and trifenatate . the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptas contains lactose '), magnesium stearate . what temybrric
zinforo is an antibiotic medicine that contains the active substance cefaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues around the skin . it is used to treat an infection of the lungs called ' pneumonia '. zzinforoe is used in adults . zininforoe works by killing certain bacteria that cause serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before taking zin foro . if any of these apply to you , tell your doctor before taking this medicine . if your doctor has told you that you have kidney problems . if this applies to you ( or you
the recommended dose of zinforo is 600 mg once a day . your doctor will tell you how many tablets to take . the recommended dose is 12 600 mg twice a day ( for example , one 600 mg tablet in the morning and one 600mg tablet in an evening ). your doctor may increase your dose to 8 600 mg every 8 weeks . if you have some infections , your doctor might increase your doses to 8 800 mg once every 12 weeks . zinforto is given by a drip into a vein . the usual dose is 5 to 60 mg once daily . your dose may be increased to 120 mg once weekly .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects : if you get any of these symptoms , you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems , asevere allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . your doctor may decide to stop treatment with zinforo or to stop it altogether . medicines that slow bowel movement may affect more than 1 in 10 people a blood test called a '
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do this in the original package in order to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine and water for injections . what zinforto looks like and contents of the pack zinofo is a pale yellowish to light yellow powder for solution for infusion in a vial . zinfforo is available in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain : pregabalin fizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic arthritis , such as diabetes or shingles . pain sensations may include burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . peripheral or central neuropathy pain may also be associated with mood changes , sleep disturbance
do not take pregabalin pfizer - if you are allergic to pregagabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking preggabal pfiser . pregibalin pfeizer may cause symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . if you experience any of these reactions , stop taking pregaabalin and contact your doctor immediately . dizziness and somnolence are common signs of accidental injury ( fall
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy and generalised anxiety disorder the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on your response to pregagalin psfizer . you should take pregafalin pfeizer once in the morning and once in a day in the evening . if you weigh 59 kg or more , you should continue taking preg
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache . common ( might affect up to 1 in every 10 people ) increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability , disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems
what pregabalin pfizer contains the active substance is pregibalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg pregaboralin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1521 ), potassium hydroxide ( e433 ). the
xadago is a medicine that contains the active substance safinamide , which increases the levels of dopamine in the brain . this is a stimulant of the brain involved in movement . in parkinson ' s disease , the most common symptom of parkinson is sudden swings in the ability to move . this may lead to difficulties moving . xadago can be used alone or in combination with the medicine levodopa , or other medicines used to treat parkinson '.
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking any of any of these : - monoamine oxidase ( mao ) inhibitors such as selegiline , rasagiline and moclobemide , phenelzine , isocarboxazid and tranylcypromine . - treatment for parkinson ' s disease or depression - pethidine , a strong pain killer . - if any of this applies to you ( or you are
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg twice a day ( one 100 mg tablet ) taken by mouth . xadadago should be taken with or without food . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg once a day . if necessary , your dose may be increased . if your doctor determines that the effect of xADago is too strong or too weak , tell your doctor . xademago should not be used in children and adolescents . x
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that may lead to collapse ) has been reported in patients with neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity , hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion , hypertension , muscle stiffness , hallucinations ( hypotension ). the following side effects have been reported with parkinson ' s disease in combination with safinamide and levodopa . other medicines and xadago tell your doctor or pharmacist if you are taking , have recently taken
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinate . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ) what xadag looks like and contents of the pack xadagon 50 mg film - coated tablets are white , biconcave film - coloured tablets of 7 mm diameter with
zytiga is a medicine containing abiraterone acetate that is used to treat prostate cancer in adult men . it is used in men whose body does not produce enough testosterone to fight prostate cancer . zytiga can be used either alone or in combination with another medicine , called hormone therapy . it can be a treatment that lowers testosterone ( androgen deprivation therapy ). it can also be used in combination or with another medication , prednisone . prednisolone is used for high blood pressure in adult patients whose body is not able to absorb enough testosterone ( fluid retention ) from their blood .
do not take zytiga if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking zytigiga if : you have severe liver damage or prostate cancer . this medicine has been shown to increase the effects of this type of cancer on other people taking this medicine . if any of these apply to you , tell your doctor before taking this type . if you have liver problems . if this applies to you ( or you are not sure ), talk to a doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . take this tablet at the same time each day . this medicine is for oral use . swallow the tablet whole with a glass of water . do not chew or crush the tablet . take the tablet with food . take it at least one hour before or one hour after food . you can take zytiga with or without food . if you take more zytig than you should if you accidentally take more tablets than you were told to , contact your
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . your doctor may decide that the level of potassium in your blood is low . your dose of potassium may need to be adjusted . other possible side effects include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet ( see section " warnings and precautions "). low blood potassium ( seen in liver function test ). high blood pressure . urinary tract infection . diarrhoea
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abiratedone acetates . - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate ( see section 2 " zytigo contains lactose "). what zytig looks like and contents of the pack - zytige tablets are white to off - white , round , 9 . 5 mm long . the tablets
hefiya contains the active substance adalimumab , a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis and paediatric crohn ' s disease paediatric non - infectious uveitis . adalimab is a monoclonal antibody . monoclal antibodies attach to specific proteins in the body . addalimumab works by attaching to a specific protein called tumour necrosis factor ( tnff ). this protein is involved in the inflammatory diseases and reduces the inflammation in these diseases .
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child ' s child has a severe infection , including tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections . if your / your child has unusual infections , or a weakened immune system . symptoms of infections may include fever , wounds , feeling tired , dental problems . if you / your / his child has moderate or severe heart failure . if he / she has a serious heart condition . allergic reaction if your , or your / her child 's
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the usual dose is one 40 mg tablet once a day . your doctor may prescribe a different dose for you . the dose may be increased to 20 mg once a week . your child ' s doctor may decide to increase the dose to 20mg once a month . the recommended dose is two 40 mg tablets once a morning . your children ' s physician may prescribe the dose of 20 mg twice a day for up to two weeks . the doctor may also prescribe the same dose for your child
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 , " warnings and precautions "): - after the last hefiya injection - allergic reaction ( e . g . heart failure ) - severe rash , hives , swollen face , hands , feet , trouble breathing or swallowing , shortness of breath , swelling of the feet . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre - used syringe may be used for a single period of
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalimab in 0 . 4 ml solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiqa 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear type
what ritemvia is ritemv contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a type in white blood cell called " b - lymphocyte ". when ritukimab sticks to the target , it stops the cell from growing and dividing . what ritemvy is used for ritemvo is used to treat a ) non - hodgkin ' s lymphoma ( a disease of the lymph tissue that affects the immune system ) in adults . it is used in adults to treat an abnormal type
do not take ritemvia if you are allergic to rituximab , other proteins that contain ritudimab . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : - are more than 6 years old - have a severe active infection - have had a weak immune system - have severe heart failure - have experienced severe uncontrolled heart disease - have granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris warnings and risks talk to the doctor or nurse before taking ritemria if you have or have ever had a hepatitis infection
your doctor will decide how much ritemvia you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the dose you need and will decide if you need any side effects . ritemv is given as a drip ( intravenous infusion ). medicines given before each ritemva administration you will be given ritem via other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . for non - hodgkin ' s lymphoma , ritemra alone
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets ,
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as monohydrate ). each ml concentrate contains 10 mg of the active ingredient in ritudimab - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemva looks like and contents of the pack ritemv is a clear , colourless solution for infusion in a glass vial . pack size of 2 vials .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostatics medicine . it is an active anti - cancer medicine . capecabine ti is used in the treatment of colon , rectal , gastric , or breast cancers . capectabine cheva is used to prevent the occurrence of colon cancer after complete removal of the tumour by surgery . cape citabine may be used in combination with other medicines .
do not take capecitabine teva if you are allergic to capecitabanine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy to this medicine , ask your doctor for advice . if you have severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines containing fluorouracil ) if you ( or your partner ) are pregnant or breast - feeding if you suffer from low levels of white cells or platelets in the blood ( leucopenia , neutropenia , thrombocytopenia ) if any of these
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabiline teva depends on your body surface area ( height and weight ). the usual dose is 1250 mg / m2 of body surface surface taken once daily . your body weight should be taken in the morning and evening . your height should be 1 . 64 mbq /
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you have any of these symptoms : diarrhoea : if you notice an increase of 4 or more bowel movements , or of 4 bowel movements at night . if you get any diarrhoehoea at night , or if you vomit more than once in a 24 - hour period . nausea : if your stomach does not empty as quickly as it should . if your doctor thinks that you may lose your appetite . stomatitis : if any of the following causes pain , red
what capecitabine teva contains the active substance is capecitabiline . capecitabe teva 150 mg film - coated tablets each film - coating contains 150 mg capecitibine . the other ingredients are : capecitobine teeva 500 mg film film - coat tablets each tablet contains 500 mg capectabine . tablet coating : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hyproellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red (
silodosin recordati contains silodosan recordati . it belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodusin recordi is used to lower the pressure in the prostate , bladder and urethra , which causes smooth muscle in these tissues . this helps to control your symptoms . silosin Recordati is used in adults to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder .
do not use silodosin recordati if you are allergic to silodosein or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodousin recordi if you have had eye surgery or cloudiness of the lens during cataract surgery . the eye is 26 sensitive to light . silododosino recordati should not be used if you experience any of these conditions . if you receive medicine that causes a loss of muscle tone in the iris ( the coloured part of the eye ), you should inform your doctor . if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of silodosin recordati is one capsule once a day . you should take silodnosin recordat for at least 8 hours . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe this purpose silodosein recordatin for at less than 4 hours . take the capsule at the same time each day . if your doctor feels that you are taking too much silodousin recordit , contact your doctor immediately . if this happens , contact
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives are the most common side effect of silodosin recordati . dizziness . dizzy , occasionally fainting , may be accompanied by feeling weak or dizzy . if you experience any of the symptoms of dizziness or faints , stop taking silodnosin recordat and seek medical advice straight away . complications from a cataract surgery ( eye surgery ) cloudiness of the lens of the eye previously treated with
what silodosin recordati contains silodusin recordat 8 mg : the active substance is silodofin . each capsule contains 8 mg silodosein . the other ingredients are mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). silodosesin recordatin 4 mg : each capsule contain 4 mg siliodosin . as well as mannola , magnesium starchate , magnesium laurilulfate . as for gelatin , tartan dioxide ( i171 ), yellow iron oxide ( e172 ). what silodnosin recordi
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzalono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzonmono is used to treat essential hypertension ( high blood pressure ) in adults . the high blood blood pressure is not caused by any other condition . high bloodpressure can damage blood vessels in several organs , which can lead to heart attack , heart or
do not take kinzalmono if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). if you think this applies to you , tell your doctor before taking kinzdalmono . if you ( or your child ) are more than 3 months pregnant . warnings and precautions talk to your doctor or pharmacist before taking kzal mono : if you have a possible pregnancy ( see pregnancy section ). if your doctor has told you that you have severe liver problems ( such as cholestasis or biliary obstruction ) or problems with drainage of the bile
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the tablets should be taken with or without food . you should take kinzalmono at the same time each day . if you take more kinzdalmono than you should if you have taken more tablets than you have been told to , talk to a doctor or go to the nearest hospital straight away . your doctor may decide to change your dose or stop treatment . if high blood pressure has been reported in patients treated with kinzallmono 40
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious and need immediate medical attention : sepsis ( blood poisoning ) is a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) cardiovascular events uncommon side effects : uncommon ( may affects up to one in 100 people ): urinary tract
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . once your medicine has been taken out of your refrigerator , it must be used within one hour . do this by referring to the date of the first opening of the blister . do away with the blister and write the date on the blister after ' exp '. do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol , magnesium stearate . what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round and flat . kinzaloo is available in blister packs of 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product containing lonoctocog alfa . afstylfa is used to treat bleeding episodes in adults with haemophilia a ( inborn factor v iii deficiency ). factor v viii is a naturally occurring component of blood clotting and is required to clot the blood . patients with an increased tendency to bleed have been shown to have higher levels of factor v ii in their blood than in patients with haophilia b . afsta helps blood to clot and is used in adults .
do not use afstyla if you have had an allergic reaction to afstila or if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor or pharmacist before using afstela . the dose and the batch number should be recorded in your treatment diary . do not use more afstla than your doctor has recommended . allergic ( hypersensitivity ) reactions are not uncommon in patients receiving afststylfa . symptoms of allergic reactions may include hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure ( anaphylaxis ),
your treatment will be overseen by a doctor experienced in blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the dose of afstyla you receive will depend on the severity of your disease the site and the bleeding your clinical condition . reconstitution and administration general structures the powder and the solvent ( liquid ) should be used immediately after reconstition . if the solvent is not clear or colourless , it should be dissolved in water or solvent ( see section " aseptic conditions "). afstlva may be used with
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives generalised urticaria ( itchy rash , tightness of the chest , difficulty in breathing , wheezing ), low blood pressure , dizziness ( anaphylaxis ), bleeding caused by factor viii medicines ( inhibitor antibodies ) ( see section 2 " warnings and precautions "). very common ( may affect more than 1 in 10 people ) - if previous treatment with factor v iii was not well tolerated , it may be up to 150 days before treatment . uncommon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product may be stored at room temperature ( up to 25 ) for a maximum period of 3 days . keep afstylea in theouter carton to protect it from light and moisture .
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu ( 2 . 5 mg ) lonoectocog . each ml of solution contains 100 iu lonoxtocog aluminium . after reconstitution with 2 .5 mg lonoactocog , each ml contains 200 iu of lonoCTocog alpha . each 1000 iu vial of solution containing 2 . 0 mg loroctocag alfa is supplied as a single vial . each 1500 iu / ml vial is supplied in a single pack . after initial
what praxbind is prax bind contains the active substance idarucizumab . idarucaizumb is a recombal agent of dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . what praxBind is used for praxbinding is used to rapidly trap dabigATran in the blood . what is praixbind used for ? prax binds to pradxa in patients who are undergoing emergency surgery or who need urgent procedures to stop uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( hfld ). if your doctor has prescribed the substance sorbitol ( e420 ) for you . warnings and precautions talk to your doctor or pharmacist before taking this medicine . serious adverse reactions have been reported with the use of this type of medicine in combination with dabigatran . other medicines to prevent blood clots dabigitran is a substance that is naturally present in the body and helps to prevent
the recommended dose is 5 mg / kg ( equivalent to 2 . 5 mg dabigatran ). this medicine will be given to you by a doctor or nurse . your doctor will decide how much praxbind you need . the recommended dose of this medicine is 5mg / kg . your dose will be decided by your doctor or another healthcare professional . this medicine may be given into a vein . your healthcare professional will administer this medicine to you at the start of your treatment . if you have problems with blood clot formation , your doctor may give dabigATran to you 24 hours after you have been given this medicine . if this
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what praxbinding looks like and contents of the pack prax bind is a clear to slightly opalescent , colourless to slightly yellow solution in a butyl rubber stopper and an aluminium cap . each pack contains one vial .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat adults with certain types of brain tumours : - newly - diagnosed glioblastoma multiforme . temormac is first given together with radiotherapy ( concomitant phase of treatment ) and monotherapy phase oftreatment ( phase 3 ). - malignant glioma : - gliotherapy : - anaplastic astrocytoma . temomac is indicated for standard treatment in adults .
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine ) or dtic . signs of allergic reaction may include feeling itchy , breathlessness , wheezing , swelling of the face , lips , tongue or throat . if blood cells are severely reduced ( myelosuppression ) or your white blood cell count and platelet count are severely decreased . these blood cells help you in fighting infection and are important for proper blood clotting . tem
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dose and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past . your doctor may also give you other medicines ( anti - emetics ) to help prevent temomedicus from causing nausea and vomiting . if you currently have newly - diagnosed glioblastoma multiforme , treatment will be divided into two phases : treatment with radiotherapy (
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures , convulsions , fever , chills and severe headache , stop temomedac treatment and seek medical help immediately . if this happens , you may experience a reduction in certain kinds of blood cells ( increased bruising or bleeding , anaemia , reduced number of red blood cells , fever and reduced resistance to infections ). the reduction in blood cell counts may be due to anaemia ( aplastic anaemia ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiratory date refers to the last day of that month . do store above 30 . do away with any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide . temomedic 5 mg : each capsule contains 5 mg temozolsomide ( as temozoleomide ). temomedoc 20 mg : one capsule contains 20 mg temzolomides ( as mesolomid ). temormac 100 mg : two capsules contain 100 mg tem ozolomine ( as semolomod ). temarmac 140 mg : three capsules contain 140 mg temosolomile ( as besilate ). - the other ingredients are : capsule contents : temomedacon 180 mg : capsule shell :
cialis is a treatment for adult men with erectile dysfunction , a condition where a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis helps to provide a hard erect penis for sexual intercourse . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works by helping the blood vessels in your penis relax . this helps your penis to work better . this lowers the amount of blood that your penis produces . this improves your penis ' s ability to work and improves your erectile function . ceral
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are intolerant of organic nitrate or nitric oxide donors ( such as amyl nitrite ) - medicines (" nitrates ") used to treat angina pectoris (" chest pain ") warnings and precautions talk to your doctor before taking ciali . these medicines may increase the amount of nitrate in your blood . - if any of these apply to you , tell your doctor . - you have serious heart disease -
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablets whole with a glass of water . the tablets can be taken with or without food . the usual starting dose is 5 mg once a day , but your doctor may increase your dose to 2 . 5 mg if necessary . if you take more cialises than you should if you accidentally take too many tablets , contact your doctor . if possible , show them the pack . if necessary
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes , frequency not known ) chest pain ( may occur with nitrates , frequency cannot be estimated from the available data ) priapsim may cause a prolonged and possibly painful erection . if you have this impression , talk to your doctor or pharmacist . cialis may cause an erection that lasts for up to 4 hours . contact your doctor immediately if you experience sudden loss of vision . frequency not available other side effects include : common ( may affect up to 1 in 10 people
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are lactose monohydrate ( see section 2 " cialises contains lactose "), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . - film - coating : lactosemonohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), ironoxide red ( e132 ), talc .
enyglid is an oral antidiabetic medicine containing repaglinide , which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyglide is used to treat type 2 diabetic in adults . treatment is usually started with diet and exercise and weight reduction . your blood blood sugar may be increased when you start taking enygalid on its own or on metformin . diabetes is also a
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low . if you suffer from diabetic ketoacidosis . if your doctor has told you that you have a severe liver disease . if any of these apply to you ( or you are not sure ), talk to your doctor . if this applies to you , tell your doctor before taking eny glid . if a severe kidney disease has been reported . if if you know that you suffer or have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the usual starting dose is 30 mg once a week for 4 weeks . your doctor may increase your dose to 30 mg every 16 weeks . if your blood sugar is too low , you may take a hypo . do not take a double dose to make up for a forgotten tablet . if you have any further questions on the use
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of enyglid is hypoglycasemia ( may affect up to 1 in 10 people ). hypoglycemic reactions are generally mild / moderate . hypocaemic unconsciousness may lead to coma . allergy allergy ( may occur in up to one in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . anaphylactic reaction ( see section 2 ). other side effects ( may include : common ( may affects up to1 in 10
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg repagginide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) ( see section 1 " eny glid contains red iron oxide " e172 ). see section 2 " enyaglid contain red ironoxide ( e 172 "
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azaccitidine myan is used for azacinidine myla is used to treat adult patients with certain types of myelodysplastic syndromes ( mds ). mds is a form of chronic myelomonocytic leukaemia ( cmml ). acute myeloid leukaemic ( aml ) is a group of diseases that affect the bone marrow and which affect normal blood cell production . what is azicitidine yourlan used for ? azacnitidine mygal
do not take azacitidine mylan if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). if you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacnitidine myl if you : have decreased counts of platelets , red or white blood cells . have kidney disease . have liver disease . had a heart condition or heart attack . have lung disease . your doctor will do blood test before you start treatment with azacididine myla . your liver will be checked regularly during treatment with this medicine . your dose
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will decide how much azaccitidine myl to give you . your dose of this medicine will depend on your height and weight . azac citidine myla is given every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcutaneously ) or under the sun ( subbedaneously ). it is given by subcutaneous injection ( subtype ). this is usually done under the same skin as in
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue . these could be symptoms or signs of kidney failure . a fever . these might be signs of an infection . low levels of white blood cells . chest pain ,
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the vial in the original package in order to protect from light . after reconstitution , the suspension must be used within 1 hour . the azaccitidine myl suspension must not be mixed with water for injections . the suspension should be stored in a freezer ( 2 - 8 ) for up to 8
what azacitidine mylan contains - the active substance is azacinidine . one vial of powder contains 100 mg azacididine . after reconstitution , 4 ml of water for injections is sufficient . the reconstituted suspension contains 25 mg azaitidine . - the other ingredient is mannitol . what azacituidine myl looks like and contents of the pack azacitonidine mylon is a white powder supplied in a glass vial containing 100 mg of azaccitidine . pack sizes of 1 and 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprost is a prostaglandin analogue ( analogue ) in the eye . timolols is a beta blocker that reduces fluid within the eye and reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye in adults with an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . - if the child has wheeziness , difficulty in breathing , long - standing cough or breathing problems . - tell your doctor if your baby has severe hay fever or a slow heartbeat . - talk to your doctor before taking duotra if your newborn has heart failure ( a disorder of heart rhythm with
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . do not use duotrav in your eye or eyes . duotrave is for use in both eyes . do this by yourself or with a caregiver . do it by yourself , or with someone else . duetrav is for oral use . do the same for your eyes . use duetrel with food and drink . try to use it at the same time each day . do these steps as described in this leaflet . do them at the end of this leafle . do use dudose
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops should be swallowed whole with water . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) the eye eye redness . common side effect ( may effect up to 1 in every 10 people ), the eye surface inflammation ( surface damage ) can cause eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms of eye irritation such as burning and stinging can be seen in the following pictures . uncommon side effects : ( may affects up to1 in 100
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . store in the original package in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substances are travoprost and timolol . each vial contains 40 mg travaprost ( as 5 mg timolols ). - the other ingredients are timolole maleate , polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg - the solvent is boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydrochloride , and hydrochlorIC acid . - the acidity levels are measured by the following measures : acidity amounts (
nplate ' s active ingredient is romiplostim . it is a protein that is used to treat low platelet counts in adults with a type of immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body ' s immune system . platelets are important in keeping the number of platelets in your blood at a normal level . they help to prevent blood clots from forming . very low platelets can lead to bruising and serious bleeding ( see section 1 " nplate contains lactose "). nplate works by helping your spleen removed
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before taking nplate : if you have a low blood platelet count ( thrombocytopenia ) if you take n plate . your platelet counts may increase . this is linked to the formation of blood clots . if you suffer from blood clotting , you should tell your doctor . if any of these apply to you , tell your physician . if your
nplate is given to adults and adolescents ( from 1 to 17 years of age ) who are able to use nplate . nplate is injected under the skin ( subcutaneous ) and is given every 1 month . your doctor will decide how much nplate you need . your dose of nplate will depend on your platelet counts . your physician will take regular blood samples to check your platelets and your plate clot count . your blood will be tested regularly to check that your platelett count is within the normal range . children and adolescents from 1 year to 17 kg your doctor may also check platelet count depending on your body
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache allergic reaction upper respiratory tract infection common ( might affect up in 1 in every 10 people ) bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin , flushing ( blood clot in a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , indigest
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do store above 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains - the active substance is romiplostim . nplate 125 mg powder for solution for injection contains 230 mg romipliplostime . each vial of nplate 250 mg contains 375 mg romplostim in a deliverable amount of 0 . 25 ml solution . each ml of solution contains 125 mg romclostim ( as an injection ). each vials of n plate 250 mg contain 375 mg of romiplustim (as an injection ) in a deliveredable amountof 0 . 5 ml solution , each ml contains 250 mg romoplostim and each ml delivers 625 mg romlost
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd causes the muscles around the airways to tighten , making breathing difficult . this medicine works by tightening these muscles in the airway making it easier for air to get in and out of the lungs . this helps to open the air passages and makes it easier to get out of and out . this means that
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovaner . - if your doctor has told you that you have kidney problems . - tell your doctor if you have an eye problem called narrow - angle glaucoma . - you may have difficulty passing urine . treatment with tovanOR breez inhaler should be stopped immediately if you experience tightness of the chest , coughing , wheezing or breathlessness .
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is one inhalation each day for 24 hours . the recommended starting dose is one 75 mg inhalation dose . always use this type of this product exactly as described in this leaflet or as your caregiver will tell you . this medicine should be used in combination with an inhaler and capsules ( in blisters ). the medicine is inhaled using inhalation powder . the capsules should be swallowed whole
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms glycoprroniumbromide and 50 microgram s glycopyronium . - the delivered dose is equivalent to the delivered delivered dose . - each delivered dose of the inhaler contains 44 microgram glycopirronium per kg of body weight . - - the other ingredients are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovanorbor breezy inhaler 44 micro
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which are important for calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms such as : ( schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour , emotional flatness , depressed , guilty , anxious or tense . in bipolar disorder , these may include feeling " high ", having excessive amounts of energy , needing much less
do not take adasuve if you are allergic to loxapine or any of the other ingredients of adasuvo ( listed in section 6 ). if you have been told that you have symptoms of wheezing or shortness of breath , as these may be signs of lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness and shortnessof breath . 25 if you suffer from neuroleptic malignant syndrome ( nms ), which may be symptoms of antipsychotic medicines . if you develop these symptoms
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day ( for 2 weeks ) and 4 . 5 mg twice daily ( for 4 weeks ). you should use adasuve every day , at the same time each day . you should try to take adasuves at the right times of the day , with food and drink . you may need to take it with or without a meal . you can take adasve with or just after food . you must take adamsve with food or drink . it
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects : - any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness , which may become irritating and may affect your airways ( asthma or copd ). - light - headedness or fainting . these may be signs of a lowering of your blood pressure . - worsening agitation , confusion , fever and muscle stiffness . these could be signs that you have a severe condition called neuroleptic malignant syndrome . other side effects include : very
keep out of the reach and sight of children . do not use adasuve after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do away with adasuvet if you notice any visible sign of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxepine . one delivers 4 . 5 mg loxpine . what adasuves looks like and contents of the pack adasuvel 4 . 0 mm is a white to off - white plastic inhaler with " loxphine " printed on the cap . each inhaler is sealed with a sealed foil pouch . adasuvet 4 . 3 mm is available in packs containing 1 or 5 inhalers . not all pack sizes may be marketed .
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent . it belongs to a group of medicines called cytokines . what azaccitidine betagarm is used for azaciticidine betafarm is for use in adults . azacituidine betaparm is given as a stem cell transplantation in adult patients with higher - risk myelodysplastic syndromes ( mds ) and chronic myelomonocytic leukaemia ( cmml ). acute myeloid leukaemic ( aml ) is a group or combination of diseases
do not take azacitidine betapharm if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). if you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitine betapham if you : have decreased counts of platelets , red or white blood cells . have kidney disease . have liver disease . had a heart condition ( heart attack ). have lung disease . blood test results before and during treatment with azacididine betabarm , your doctor will check whether you have enough blood cells to protect your
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how much azacita betapham you need . your dose of this medicine will depend on your height and weight . azaccitidine betabarm is given every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcutaneously ) or under the sun ( subbedaneously ). it is given by injection under the same skin ( on the thigh , tummy or upper arm ).
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue . these could be symptoms or symptoms of kidney failure . a fever . these might be signs of an infection . low levels of white blood cells . chest pain ,
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the vial label and the carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the vials in the outer carton in order to protect from light . do away with any unused azaccitidine betabarm suspension . after dilution , the suspension should be used within 8 hours . if not used within eight hours , the azacididine betafarm suspension should
what azacitidine betapharm contains - the active substance is azacinidine . each vial contains 100 mg azacitasidine . after reconstitution , 4 ml of water for injections is sufficient . the reconstituted suspension contains 25 mg azaitidine . - the other ingredient is mannitol ( e421 ). what azaccitidine betabarm looks like and contents of the pack azacitonidine betafarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacididine .
the active substance of cerdelga is eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is inherited condition in which a substance called glucosylceramide is not removed from the body . this substance is mainly produced by the spleen , liver and bones . when eliglustate is taken with glucosophceramide , it can cause glucosolceramide to build up in your affected organs . this medicine is used to treat this condition . your doctor will test for this medicine before you start using cerdelaga . if you use more cer
do not take cerdelga if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). if you have been taking medicines called moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 or moderate cyc3a inhibitors ( i . e . erythromycin and itraconazole ). these medicines are used to improve your body ' s ability to use its own blood . warnings and precautions talk to your doctor or pharmacist before taking cerdelg . cerdelgas is only used in patients with medicines that
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of metaboliser twice a day . the amount of metabolizer that you need varies depending on your condition and body surface area . the usual dose is two tablets of metabolise twice a week . swallow the tablets with a glass of water . the maximum recommended dose for adults is 84 tablets once a day ( one tablet in the morning and one tablet at the evening ). swallow the tablet whole with a drink of water ( one glass of the morning , one tablet with the evening meal )
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and sleeve after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustit . - the other ingredients are microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ), shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelgas looks like and contents of the pack cerdelg capsules are a peach
the active substance in zoledronic acid hospira is zoledoracid , which belongs to a group of substances called bisphosphonates . zoledron acid works by attaching itself to the bone and slowing down the rate of bone change . it is used to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the other bone ). it reduces the amount of calcium in the blood in adult adult patients when the tumour has spread to the surrounding bone . this condition is known as tumour - induced hypercalcaemia ( tih ).
your doctor will carry out blood tests before and during treatment with zoledronic acid hospira and will decide whether you should be treated or not . your doctor will decide if you should receive treatment with the active substance zoledor acid hospir . if you are allergic ( hypersensitive ) to zoledron acid or another bisphosphonate ( the group of substances to which zoledic acid belongs ), or any of the other ingredients of zoledoral acid hospiar ( listed in section 6 ). if you think any of these apply to you , tell your doctor or pharmacist before receiving zoledar . if any of
the doctor treating you will administer zoledronic acid hospira in combination with bisphosphonates intravenously ( into a vein ) with ' iv ' administration . the recommended dose is one tablet per day . dehydration is recommended . how much zoledron acid hospir is given the recommended starting dose is 4 mg . if you have a kidney problem , your doctor may lower your dose depending on your kidney problem . how zoledic acid hospiar is given you will be given a course of treatment to prevent bone complications ( including bone metastases ). how much is given each infusion of zoledor acid hospire is given as
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the following side effects have been reported with zoledic acid hospir : common ( may affect up to 1 in 10 people ): severe kidney impairment ( may be seen in blood tests ) low level of calcium in the blood uncommon ( may effect up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge , numbness or a feeling of heaviness or loosening of a tooth ) bone damage in the jaw ( osteonecrosis
keep out of the reach and sight of children . do not use zoledronic acid hospira after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicinal product does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zoledronic acid hospira contains - the active substance is zoledic acid . one vial of zoledor acid contains 4 mg zoledron acid . - the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledico acid hospir looks like and contents of the pack zoledidronic acid hospira is a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains one vials of concentrate .
varuby contains rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy . these nerve cells are important in controlling the amount of virus that can enter the brain and help fight off the effects of vomiting . if you feel sick ( vomit ) or are sick ( being sick ) after taking rolapit , these nerve cell cells help fight against nausea and vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you have an herbal medicine called st john ' s wort ( hypericum performatum ). if your doctor has told you that you have depression or difficulty sleeping ( see section 2 " warnings and precautions "). if you think this applies to you , tell your doctor before taking this medicine . warnings and conditions 27 if you suffer from severe liver or kidney problems . if you take certain medicines ( e . g . rifampicin , used to treat tuberculosis or other infections )
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 180 mg once a day for up to 90 days . swallow the tablet whole with water . you can take varuby with or without food . you may take it with or just after food . it is best to take the tablet at least 2 hours before your chemotherapy cycle . if you take more varubys than you should if you have taken more tablets than you were told to , contact your doctor . if possible , show them the pack . if your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect more than 1 in 1 , 000 people ) symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swelling or skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately and receive appropriate treatment . other side effects include : very common ( may affects more than one in 10 people ) headache constipation feeling tired uncommon ( may affecting up to 1 in 100 people ) sore or
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg rolapit . - the other ingredients are lactose monohydrate ( see section 2 under ' varubey contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . - film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varubsy looks like and contents of the pack varubdy is
what enerzair breezhaler is enerzalder contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and the active substance glycopyronium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs . this helps to open the airways wider and allows air to get in and out of the lungs more easily . mometsone fruate belongs to a class of medicines known as corticosteroids . corticostromes reduce the swelling and
do not use enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice before using enerzir . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : - have heart problems - have an irregular or fast heartbeat - have thyroid gland problems - diabetes - have high blood sugar - have seizures - have severe kidney problems - suffer from severe liver problems - experience low level of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the medicine should be inhaled by mouth . you should inhale enerzair breezhaler every day until your asthma has gone away . your doctor will check your symptoms regularly while you are using it . how to use enerz air breez inhaler use enerzeair breezehaler as an inhaler and capsules . the inhaler is for inhalation use only . the capsules should be swallowed whole with water . do not chew , crush or break the capsules . do this to remove the
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious and need immediate medical attention : stop using enerzair breezhaler and see a doctor immediately . very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives . allergic reaction may occur . other side effects other side side effects include the following side effects : common ( might affect up to 1 in every 10 people ) sore throat , runny nose , sudden difficulty breathing , feeling of tightness , wheez
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from light . the capsules should be used within one month after first opening . do this if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), mometasone furoate and 150 micrograms of indacataterol (( as acetates ) and 63 microgram of glycopyronium bromides . each capsule contains 50 microgram glycopierronium and 160 microgram mometsone furuate . the delivered dose is delivered into the mouthpiece of the inhaler . each delivered dose contains 114 microgram indacate , 58 microgram ( 3 . 0 mill
clopidogrel acino pharma gmbh contains the active ingredient clopidigrel which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrelacino pharmá gmbhs is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events , which can lead
do not take clopidogrel acino pharma gmbh - if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of clopidineogrel agabiline ( see section 6 ). - if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking clopridogrelacino pharmae gmbhl . warnings and precautions talk to the doctor
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopridogrel aclara gmbhl per day to be taken orally with or without food . you can take clapidogl acino pi gmb h with or just after food . if you take more clopidoogrelacino pharmae gmbhs than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the following side effects have been reported with clopidineogrel : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) rare ( affects less than 1 users in 1 , 000 ) very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) very common : may affect more than one in 10 people contact your doctor immediately if you experience : fever , signs of infection or extreme tired
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplogrel aclarifilate if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help
what clopidogrel acino pharma gmbh contains - the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). - the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmá gmb h looks like and contents of the pack clopidiog
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it is used in combination with medicines called ' antiretroviral medicines '. the active substances are doravirine ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine ( also a nucleosiderase analogue reverse transcriptases inhibitor ( rrti ). the other active substances in delstrigo are tenofovir disoproxil ( also known as a nucleotide analogue reverse transcriptase inhibitor , nrti ) and tenofavir dis
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 . do not take the following medicines : carbamazepine , oxcarbazepine and phenobarbital and phenytoin ( medicines used to prevent seizure ) rifampicin and rifapentine ( medicines to treat tuberculosis ) st . john ' s wort ( hypericum perforatum ) a herbal remedy used to treat depression and anxiety . products containing mitotane (
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of a single tablet once a day . your doctor will tell you how many tablets to take . the usual dose for hiv infection is 1 tablet once daily . your dose may be adjusted by your doctor if you take certain medicines ( e . g . doravirine ). your doctor may prescribe medicines that lower your dose . taking this medicine swallow the tablet whole with water . do not chew or crush the tablet . if you have any further questions on the use
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms pain ( stiffness ) feeling tired fever blood tests increased levels in liver enzymes uncommon ( may affects up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion , suicidal thoughts 45 trouble concentrating memory
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substance is doravirine . each tablet contains 300 mg lamivudine ( equivalent to 245 mg ) and tenofovir disoproxil ( as fumarate ). the other ingredients are croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumate . a coating material containing carnauba wax e903 , hyproellose , iron oxide yellow ( e172 ), lactose monohydrate
spravato contains esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps control your depression and relieves the symptoms of depression such as feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in combination with another antidepressant , which is used every 2 weeks . if you have any further questions on the use of antidepressant medicines , ask your doctor or pharmacist .
do not take spravato if you are allergic to esketamine or any of the other ingredients of ketamine ( listed in section 6 ). if you have an aneurysm ( a weak spot in a blood vessel wall that bulges out ) or bleeding in the brain . if you recently had a heart attack . within 6 weeks of taking spravo . if any of these apply to you , tell your doctor . spravat may cause a temporary increase in blood pressure . serious complications in these conditions can occur , and spravatin should be stopped . if this happens , tell the doctor before taking this medicine .
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the spravato nasal spray must be used within 1 hour . you can use 2 or 3 nasal spray devices . you may use one nasal spray device for 4 hours . you should use spravatos for at least 2 hours . if you use more spravat than you should if you have used more spradato than you have been told to , contact your doctor . if possible , show the doctor or nurse the pack . if necessary , show them the pack of nasal spray
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ) feeling disconnected from others feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to the sun , spinning sensation ( vertigo ) vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy ( euphoria ) feeling agitated feeling anxious eyes and ears ( sense of touch are impaired or switched from reality ) irritable panic attacks change in perception 37 feeling , hearing , seeing
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravatos looks like and contents of the pack spravat is a nasal spray solution . this medicine is a clear , colourless solution supplied in a single - use nasal spray unit . spravata is available in packs of 1 , 2 , 3 or 6 nasal spray devices . eachnasal spray device is sealed in
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . this type of cancer has a change ( mutation ) in a gene called " melanoma " that makes it harder for cells to grow . zelborab targets proteins that are involved in the growth of your cancer .
do not use zelboraf if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if any of these apply to you , tell your doctor or pharmacist before using zelberaf . allergic reactions if allergic reactions occur while you are being treated with zeloraf , tell the doctor or nurse immediately . if you have any symptoms of an allergic reaction , such as swelling ofthe face , lip or tongue ), difficulty breathing or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 mg once a day for up to 8 weeks . your doctor may increase your dose to 4 mg twice a day if you experience side effects . your treatment with zelboraf may be interrupted if you have vomiting . take zelbaf at the same time each day . take the tablet with food . zelbaraf should be taken on an empty stomach . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you take more z
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelbaf and contact your doctor immediately if you notice any of the following symptoms : - skin rash , blistering , peeling , discoloration of the skin shortness of breath - a cough , fever or chills ( pneumonitis ) - difficulty or pain when swallowing - chest pain , heartburn or acid reflux ( esophagitis ) tell your doctor if you experience any changes in your skin . other side
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and blister after exp . the expiratory date refers to the last day of that month . this medicine does not require any special storage conditions . do this by referring to the package leaflets which are included in the blister . do these measures to help protect the environment .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of ve murafenb ). - the other ingredients are : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of the pack z
duoplavin contains the active substance clopidogrel , which is also known as acetylsalicylic acid ( saa ). it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumping , blood vessels relax and blood vessels expand . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken to prevent blood clumps forming in hardened arteries , a process known as atherostrombotic events
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been previously treated with other products called non - steroidal anti - inflammatory products . if your doctor has told you that you have painful and / or inflammatory conditions of muscles or joints . if this applies to you , tell your doctor . if any of these apply to you ( or you are not sure ), talk to your doctor before taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take duoplavin at the same time each day . your doctor will tell you how many tablets of your medicine to take . if you take more duoplin than you should if you have accidentally taken too many tablets , or if someone else has taken your tablets , contact your doctor immediately . if possible , contact the nearest hospital emergency department immediately . you may be at increased risk of bleeding . if necessary , contact a doctor or the nearest casualty
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), which may cause bleeding mainly under the skin ( red pinpoint dots and /or confusion ), which can be severe ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any visible sign of deterioration . do so and return the pack to your pharmacist . donot throw away any medicines via wastewater or household waste . ask your pharma how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 tablets of the active substances : clopidogrel ( as acetylsalicylic acid (asa ) 75 mg : clapidogel ( as hydrogen sulphate ) 75mg : acetylSalicylic acids ( as mannitol , macrogol 6000 ), microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil ( see section 2 ' duopllin contains hydrogenatedcastor oil '), stearic acid and colloidal an
simbrinza contains two active substances called brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonididine tartrates belongs to the group of medicine called alpha - 2 adrenergic receptor agonists . it reduces pressure within the eye . simbrinz is used in the eyes of adults and adolescents aged 18 years and older to treat eye conditions such as glaucoma , ocular hypertension and high pressure on the eyes .
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides ( medicines used to treat diabetes or infections ) if any of these apply to you , tell your doctor before taking simbratinza . if you have been taking diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors ( medicines to treat depression or parkinson ' s disease ). if you take certain antidepressants . if any antidepressant medicines have been taken in
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . simbrinza should be used in both eyes . avoid contact with the drops in both of your eyes . wash your hands thoroughly after using simbrinusza ( see section 1 , " how to use simbrinsza "). remove the cap and snap collar from the bottle . hold the medicine with both fingers . tilt the bottle back . gently squeeze the bottle , pointing down . gently pull down the thumb and fingers . pull down your head , back , and press the tip
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ): signs of an allergic reaction may include severe skin reactions , rash , redness or itching all over your body , eyes trouble breathing , chest pain , irregular heart beat , tell your doctor immediately extreme tiredness or dizziness . other side effects that have been reported with simbrinza with other medicines ( such as brinzolamide or brimonidine ) include : common side effects ( may affect up to 1 in 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brin zolamide ( corresponding to 2 mg of the brimonididine tartate equivalent to 1 . 3 mg of Brimonidine ). - the other ingredients are benzalkonium chloride ( see section 2 " simbrinusza contains benzalkonaium chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid , sodium hydroxide , purified
what filgrastim ratiopharm is filgrasteim ratisopharm contains the active substance filgrasterim . filgrastersim is a protein produced by biotechnology in the laboratory called escherichia coli . it is a natural protein produced in the body called granulocyte - colony stimulating factor ( gsf ). filgrustim stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . filgnastim helps to increase the number of white blood cells in your body . fil grastim rad
do not use filgrastim ratiopharm if you are allergic ( hypersensitive ) to filgrasterim or any of the other ingredients of filgraspim ratinopharm . if you think any of these apply to you , tell your doctor or pharmacist before using filgrasteim ratisopharm : if you have a cough , fever and difficulty breathing . if this applies to you ( or you are not sure ), tell your physician straight away . if any of those apply to your ( or your child ' s ) medical history , tell them straight away , as they may cause side effects . if
what filgrastim ratiopharm is and how it works filgrasterim ratisopharm will be given to you by a doctor or nurse . you will be asked to take filgrasteim ratiotopharm for one month . filgrastersim ratitopharm treatment with filgrateim raticoopharm : the usual dose of chemotherapy is 0 . 5 mg per kilogram body weight . you may be given up to 60 mg per day for 30 days . your treatment will last approximately 14 days . some disease types may be more severe . filbrastim ratiopharm should be
you should not be given filgrastim ratiopharm if you have sickle cell disease 57 you should tell your doctor if you get left upper abdominal pain or pain at the tip of your shoulder . if you suffer from a spleen disorder ( see section 4 . possible side effects ). your doctor will do regular blood tests before you are given filbrastim ratiopharm . neutrophils ( a type of white blood cells ) are a type in your blood . they are important in helping your body to fight infection . your doctor may also check your blood before and during treatment . other medicines and filgrAST
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . donot use filgrimastim piriopham if you notice that the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasterim . each ml of solution for infusion contains 60 mg of filgrgrastime . filgrasteim ratisopharm 30 mg : 0 . 5 ml solution for injection contains 30 mg of filmgrastrim in 0 . 0 ml solution . filgnastim ratiopharm 48 mg : 1 ml solutionfor injection contains 48 mg of the active ingredient filgraldim in 0. 8 ml solution ( see section 2 . filgrimastim radiopharms contains sodium hydroxide , glacial acetic acid
what riluzole zentiva is riluxole zenta contains the active substance rilusole . it works by stimulating the nervous system to produce its own signals . what rilzole zintiva is used for rilizole zertiva is given to adults with amyotrophic lateral sclerosis ( mds ) or motor neurone disease ( mld ). mds affects the nerve cells responsible for muscles , causing weakness , muscle waste and paralysis . mld is a consequence of the destruction of nerve cells in motor neurones disease . mds is caused by too much glutamate ( a chemical messenger )
do not take riluzole zentiva if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). if you have any liver disease . if you experience increased blood levels of some enzymes of the liver called transaminases . if this applies to you , tell your doctor before taking rilzole zenta . if any of these apply to you ( or you are not sure ), tell your physician before taking this medicine . if your doctor thinks any of this applies , tell the doctor before you take rilsuzolezentiva . if there are any signs
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . the tablets should be taken by mouth at least 12 hours apart . if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible take rilzole zenta with food . if a child swallows some tablets , contact your physician or pharmacy . if the child swalloses some tablets contact your nearest emergency department straight away . if your child swallves some tablets or
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ) during treatment with riluzole zentiva . this may be due to a decrease in the number of white blood cells . your doctor will take a blood sample to check for these changes . white blood cell counts are important in fighting infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may
what riluzole zentiva contains - the active substance is rilusole . - the other ingredients are anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zenta looks like and contents of the pack the tablets are white , round , biconvex , with " 50 " debossed on one side and " ril " debrossed on the other side . r
the active substance in emgality is galcanezumab , a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ). migraine is a condition in which the body produces increased levels of cgrf . emgalis is used to treat migraine in adults , adolescents and children aged 4 years and older . migraines are usually mild to moderate . emigality can be used in adults and adolescents of all ages . the frequency and severity of migraine headache varies from person to person , but it is important that you continue to take emgally as long as it helps to improve your
do not take emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease if you suffer from serious cardiovascular diseases if you think any of these apply to you , tell your doctor or pharmacist . allergic reactions emg abnorm may cause serious allergic reactions . these reactions may occur within 40 minutes of a serious allergic reaction . such signs are usually mild to moderate and disappear without side effects . see section 4 . children and adolescents emgally is not recommended for children and teenagers under 18 years of age . other medicines and
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg emgally given as an injection under your skin ( subcutaneous injection ). your doctor will decide how much emgalia injection you need and will give you proper training . if you use more emgals than you should if you forget to use emgonality if you miss a dose , inject it as soon as you remember . however , if it is less than 240 hours until your next dose , skip the missed dose and inject the next dose at the usual time
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps . other side effects tell your doctor or pharmacist if you notice any of the following : very common side effects ( may affect more than 1 in 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store at room temperature ( up to 30 ) do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcanesumab in 1 ml solution . - the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the colour is slightly yellow . the syringe is supplied in a pack of single - dose pens of 1 , 2 , 3 or multipacks of one .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hepatic occlusion ) in which the blood vessels in the liver become damaged and blood clots form . it has been given to you by your doctor or nurse , or by medicines you have received prior to a stem cell transplantation . defibrorotide works by helping the blood vessel to relax and form the blood clasts . your doctor has prescribed this medicine for you because you have not been trained .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). if you have been previously treated with other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) if you take medicine to prevent bleeding ( for example , if you experience heavy bleeding after a blood transfusion or surgery ). if your doctor has told you that you have problems with blood circulation or a constant blood pressure . warnings and measures talk to your doctor or pharmacist before using defitelo . children and adolescents do not give this medicine to children
your doctor will decide how much defitelio you should receive and how long you should be treated . the treatment with defitelinio will be started by a doctor who is experienced in the use of stem cells transplantation . it will be given into one of your veins as an ' intravenous infusion ' ( drip ). you will receive this treatment for 21 days . if your symptoms do not improve within this 21 day period , you should contact your doctor . if you have any further questions on the use or use of this medicine , ask your doctor or pharmacist . children and adolescents do not give this medicine to children under 18
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defiteloio and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people ) bleeding in general bleeding in the nose bleeding in parts of the brain bleeding in part of the gut vomiting blood bleeding in one or more parts of one of the lungs bleeding in blood in the urine and the mouth bleeding in other parts of your body ( including the skin coagulopathy ) disturbance (
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use definitelio if you notice that the solution is cloudy or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains - the active substance is defibrotide . each ml of 2 . 5 ml solution contains 200 mg of defibrorotide ( as monohydrate ). - each ml solution provides 80 mg of the active ingredient in defibotide . - the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), and water for injections ( see section 2 " defitelsio contains sodium "). what defitELio looks like and contents of the pack defiteloio is a clear , colourless solution for infusion . each
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by stopping the hepatitisc virus from multiplying in your body . it also prevents the virus from spreading to other parts of your blood . daklinz is used in combination with other medicines to treat hepatitis c infection . the other medicines that you will be given are : - daklineza alone or with other oral medicines to control hepatitis c in adults . - daclinza is used together with the other medicine that you are taking . if you have any
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you take daclinza by mouth with the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to treat epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics used to prevent tuberculosis ) dexamethasone ( a steroid used to correct allergic and inflammatory diseases ) medicines called st . john ' s wort ( hypericum
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once daily . do not take more than this recommended dose . do this if you notice a different or unpleasant taste . daklanza may be taken with some other medicines . if you take more dakinza than you should if you have taken more dailinza than your doctor tells you to , talk to your doctor . if possible , tell your doctor , pharmacist or nurse . if necessary , tell them to stop taking dakline
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza in combination with sofosbuvir and ribavirin has been associated with the following side effects : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when dakinza in tandem with sofiosbuir and ribvirin has also been associated . common ( likely to affect up in every 1 in 100 people ): headaches
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclaasvir ( as dihydrochloride ). - the other ingredients are anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate , hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) ( see section 51 " daklineza contains lactose "). what daklon
proquad is a vaccine that protects against measles , mumps , rubella , chickenpox ( varicella ) viruses . when a person is given the vaccine , the body ' s natural defences ( antibodies ) will produce its own protection against the measles , rubles , rubell and varicelluses . the antibodies help to prevent diseases caused by these viruses . proquad is used to prevent measles , measles , and rubella in adults , adolescents and children 12 months of age and older . it is used in national vaccination circles to prevent the following types of measles : - measles , - rubella and chickenpox : - the
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have a blood disorder or type of cancer that affects the immune system . treatment with medications that weaken the immunesystem ( e . g . low - dose corticosteroid therapy , asthma or replacement therapy ) if your child has a weakened immune system , a disease ( including aids ), congenital or hereditary immunodeficiency ( immune competence ) or active untreated tuberculosis if your baby has fever of 38 . 5 or low
proquad is given by injection into the muscle ( subcutaneous injection ) under the skin ( usually in the thigh or upper arm ). injections will be given into the upper muscle ( usually the thigh area ) or into the arm area . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given under the sun . injecting under the surface of the skin may increase the risk of bleeding and therefore proquad should not go into the blood vessel . proquad is injected into a blood vessel ( subbasis ). proquad can be given to adults and adolescents from 9 to 12 years of age
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : very common ( may affect more than 1 in 100 people ): seizures ( difficulty in speaking or swallowing ) rare ( may affects up to 1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ) other side side effects reported with the use of proquad are : common ( might affect up
what proquad contains the active substances are : measles virus1 , edmonston strain 3 . 00 mg mumps virus1 ( jeryllynn™ level b ) strain 4 . 30 mg rubella virus2 , strain 3 , 00 mg varicella virus3 , merck strain 3. 99 mg mrc . the other ingredients are : powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate , potassium chloride 199 and hanks ' salts ( mem , neomycin , phenol red
jylamvo is a substance that is absorbed into the body and is an anticancer medicine that reduces unwanted reactions . it is an immunosuppressive agent . it acts as an anti - inflammatory effect jylamv is used to treat rheumatic and skin diseases : active rheumatoid arthritis ( polyarthritic forms of joints ) severe juvenile idiopathic arthritis ( jia ) in children and adolescents ( 3 years of age and older ) who have not previously used non - steroidal anti -inflammatory drugs ( nsaids ) and who have inadequate o severe or disabling psoriasis . treatment is usually
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment if you suffer from a liver impairment if your doctor has told you that you have blood disorders such as bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia 34 if you know that you may have a weakened immune system if you think you have or have ever had a serious infection such as tuberculosis or hiv if you develop ulcers in the stomach or intestines if you experience an inflammation
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . your doctor will determine the dose you need and will adjust the dose of the treatment . rheumatoid arthritis and severe juvenile idiopathic arthritis severe psoriasis if you have severe psoriatic arthritis , your doctor may decide to give you jylimvo as a long - term treatment . jjlamvo is used in rheumatic and skin diseases ( jia , psor
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash and itching all over your whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising nose bleeds nausea , vomiting , abdominal discomfort severe diarrhoea mouth ulcers , black or tarry st
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from light . the medicine should be used immediately after dilution . accidental spillage may occur within 3 hours . do away with any unused medicine or waste material . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotroxybenzoate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzzoate ( e218 ), sodium methyl parahhydroxybenziate (e218 ), citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl parahydroxy benzoate and sodium methyl parahydroxybenzoates "). what jyarmvo
this medicine contains the active substance glycopyrronium bromide , which belongs to a group of medicines called bronchodilators . this medicine is used to help adults with breathing difficulties due to a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medication prevents this tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this means that this medicine helps to reduce the amount of air that gets in and around the lungs when you breathe . this helps to lower the amount that gets
do not use enurev breezhaler if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). if you have kidney problems . if you suffer from an eye problem called narrow - angle glaucoma . if this applies to you , tell your doctor . if your doctor has told you that you have difficulty passing urine . if any of these apply to you during treatment with enurevo breez inhaler , tell the doctor or pharmacist immediately . if the following happen : tightness of the chest , coughing , wheezing or
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation once a day . this medicine is for use within 24 hours of the last dose . the maximum recommended dose for adults is 75 inhalations once a week . always use this medication exactly as described in this leaflet or as your caregiver will tell you . you should check with the doctor , nurse or pharmacy if you think you are using this medicine . this leafle contains an inhaler and capsules ( in blisters ). the medicine is inh
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . tell your doctor immediately if you notice any of the following : very common ( may affect more than 1 in 100 people ): irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms are excessive thirst or hunger ( frequent urination ) rash , itching , hives , difficulty breathing or swallowing dizziness allergic reaction swelling mainly of the tongue , lips , face or throat ( angioedema ) if any of these side effects gets serious , tell your physician . some other side effects ( frequency not
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 mg glycopyroniumbromide ( equivalent to 50 mg glyopyrronIUM ). - the delivered dose is delivered into the mouthpiece of the inhaler . each delivered dose contains 44 mg glypyrronia . - the other ingredients in the inhalation powder are lactose monohydrate and magnesium stearate . what enurevo breez inhaler looks like and contents of the pack enurevan breezker 44 mg hard capsules are supplied as a white powder
what riximyo is riximusimyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a type a white blood cell called " b - lymphocyte ". when ritiximab sticks to the target , it stops the cell from growing and dividing . what rixima is used for rixigyo is used to treat adults with the following conditions : - non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue . the immune system attacks a type b
do not use riximyo if you are allergic to rituximab , other proteins , or any of the other ingredients of ritudimab ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if severe heart failure or severe uncontrolled heart disease . if any of these apply to you . warnings and precautions talk to your doctor , pharmacist or nurse before using riximusyo . if your doctor has told you that you have : - a severeactive infection at any time , at the time of treatment . - microscopic polyangi
your doctor will decide how much riximyo you will receive and how often you will be given this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you experience any side effects , talk to your doctor . riximeyo is given as a drip ( intra - venous infusion ) into a vein . medicines given before each rixiemyo administration you will take rixie with other medicines ( premedication ) to reduce the risk of side effects . your doctor may change the dose of your treatment . non - hodg
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets ,
what riximyo contains - the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient ritudimab ( 10 mg ). - the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide and hydrochloric acid ( see section 2 " rixamyo contains sodium "). what rixima looks like and contents of the pack riximusyo is a clear to slightly yellowish solution for infusion . it is supplied in
topotecan actavis contains the active substance topotecin . topotecaan activ is used to treat adults with small cell lung cancer that has not responded to chemotherapy . it is also used to prevent advanced cervical cancer that cannot be removed by surgery or radiotherapy . in this case topotan actez treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using topotocan actif if your blood cell counts are too low . do not use more topotican actf than your doctor has recommended . - if any kidney problems are serious . if any of these apply to you , tell your doctor before using this medicine . warnings and risks talk to the doctor or nurse before using any topotnican actuf . if you have severe kidney impairment
your doctor will determine the dose of topotecan actavis you will receive based on the disease and on results of blood tests . the duration of treatment is defined as follows : treatment in adults small cell lung cancer : 1 . 5 mg per square metre of body surface area for every 5 square metres of body body surface for this treatment cycle . in cervical cancer : 0 . 75 mg per sq metre of surface area , for every 3 square metres in this treatmentcycle . in patients with cervical cancer , another anticancer medicines ( such as cisplatin ) may be used . cisplin is used to treat impaired kidney function .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects serious side side effects including infections ( may affect up to 1 in 10 people ) fever . this is a sign of your general condition . local symptoms include sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . lung inflammation ( may up to up to one in 1 , 000 people ) difficulty in breathing , cough and fever . these may be signs of this severe condition called interstitial lung disease .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiratory date refers to the last day of that month . keep the vial in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 and 2 to 24 and 2 and 8 respectively . the drug product solution for dilution in solutions for infusion ( nacl 0 . 9 %) and glucose 5 mg / ml ( 0 . 5 %
what topotecan actavis contains - the active substance is topotan . each vial contains 1 mg or 4 mg topotecaan ( as hydrochloride ). after reconstitution , 1 ml of solution contains 1mg topotican . - the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotnican actis looks like and contents of the pack topottecan acti is a white to off - white , round , convex , convection , with grey bromobutylic stopper and
the active substance of rivastigmine hexal is rivestigmine . rivustigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivaldigmine works by blocking the enzymes that break down acetylCHoline : acetylchlorolinescerase and butyrylcholineseterase . by
do not take rivastigmine hexal - if you are allergic to rivastaigmine ( the active substance in rivostigminehexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a previous skin reaction ( allergic contact dermatitis ). warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking the medicine . warnings and risks talk to the doctor or nurse before taking any of your medicines : - if any patient has
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you how many tablets of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose may be 6 . 0 mg per kg of body weight . your doctor may adjust your dose depending on your response to this medicine . if you take more rivasta hexal than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show them the pack of
like all medicines , this medicine can cause side effects , although not everybody gets them . you should discuss these side effects with your doctor , pharmacist or nurse before you start your medicine . the side effects listed below are defined using the following convention : very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ): anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon ( may
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what rivastigmine hexal contains 64 the active substance is rivastaigmine hydrogen tartrate . the other ingredients are : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ) and shellac . each rivostigminehexal 1 . 5 mg / 1 . 25 mg film - coated tablet contains 1 . 05 mg of rivstigmine . each vial of each ritastigmin hexal 3 mg / 3 mg film
what cabometyx is cabometx is a cancer medicine that contains the active substance cabozantinib . it is used to treat kidney cancer , renal cell carcinoma or liver cancer in adults . it can be used alone or in combination with a specific anticancer medicine containing sorafenib . what cabomety is used for cabometrx is used in adults to treat receptor tyrosine kinases ( rtks ), which are involved in the formation of new blood vessels . by blocking the action of these proteins , cabometometyx can reduce the number of high amounts in cancer cells . how cabometrix
do not take cabometyx 45 if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabomety if you have high blood pressure , have had an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall , have diarrhoea , have recently had significant bleeding , have undergone surgery within the last month , have been undergoing surgical procedures , or have had dental surgery , have inflammatory bowel disease , crohn ' s disease , ulcerative
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor may increase your dose depending on your response to this medicine and on your treatment . if you take more cabometyx than you should if you have taken too many tablets , contact your doctor immediately . if possible , your doctor will monitor your condition and may decide to reduce your dose or stop your treatment temporarily if you experience serious side effects . your treatment with cabometx will be started by a doctor who is experienced in the treatment of diabetes . the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines : tell your doctor straight away if your side effects become severe or uncontrollable . if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea and feeling sick ), vomiting , constipation and fever . these may be signs of a gastrointestinal perforation ( a hole in the stomach or intestine ). severe or unpredictable bleeding . symptoms include vomiting blood , black stolls , bloody urine , headache , coughing up blood , swelling ,
what cabometyx contains - the active substances are cabozantinib and malate . cabometx 20 mg : each tablet contains cabozatinib ( s ) and malates . each tablet of 20 mg cabozentinib is available in two strengths : cabomety 40 mg : one tablet of cabozutinib_( s ) or malate and each tablet is available as 40 mg caboxantinab . cabobometyx 60 mg : two tablets of cab ozantinip ( s) and malacy and each tablets are available as 60 mg cabobozantanib .
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to you if you have not received prior chemotherapy . pemrexedospira will also be given in combination to cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will decide if pemetreed hospir is suitable for you if lung cancer is advanced or if
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not recommended during treatment with pemetezed hospir . - if your child has recently received a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetretted hospiar if you have or have had problems with your kidneys . before you receive pemeted hospiera , your doctor will check your blood and kidney function regularly . if you do not have enough blood cells
the dose of pemetrexed hospira that you receive is 500 mg for every square metre of your body ' s surface area . this means that your height and weight are measured in square meters ( m² ) of body surface area each day . this body surface surface area is calculated by your doctor depending on your weight and on the duration of treatment you have . your doctor will also adjust your blood cell counts . the infusion will last approximately 9 minutes . sodium chloride solution is used to dissolve pemetreed hospir in water for injection . cisplatin will be given to you by a doctor or nurse . cislatin
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection with a temperature of 38ºc or greater , sweating , or any signs of infection ( since you may have less white blood cells than normal ). infection with sepsis may be severe and could lead to death . if you have chest pain with a fast heart rate , pain , redness , swelling or sores in your mouth . allergic reaction : skin rash , burning or prickling sensation , fever . skin reactions may be serious and could be life - threatening and could result in death .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : chemical and physical in - use stability of the product has been demonstrated for 24 hours at 2 - 8 . the reconstitution solution should be used immediately . parenteral medicines : if you notice discolouration prior to administration , this medicine should be discarded . any unused
what pemetrexed hospira contains the active substance is pemetre . pemetereed hospiras 100 mg : each vial contains 100 mg pemetrion ( as pemetretrexed disodium hemipentahydrate ). pemetemetrexED hospira 500 mg : one vial of 500 mg pemexed ( as peemetrexede disodium emipenthydrate ) contains 1 , 000 mg petrexed . pemrexed dispersion in water for injection after reconstitution with the solution contains 25 mg pererexed per ml . further dil
what ganfort is ganint contains two active substances called bimatoprost and timolol . both help to control pressure in the eye . bimAToprost belongs to a group of medicines called prostamides . it works by blocking a prostaglandin analogue . timololine belongs to medicines called beta - blockers . what ganf looks like and contents of the pack gannt is a clear , watery liquid in the back of the eye , which is clear and colourless . ganart is used in adults , adolescents and children aged one year and above . gansfort is
do not use ganfort eye drops if you are allergic to bimatoprost , timolol or beta - blockers ( see section 6 " ganfear "). if you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( signs include wheeziness , difficulty in breathing and long - standing cough ). if you suffer from heart problems ( signs includes low heart rate and heart block ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before using this medicine . coronary heart disease ( symptoms include chest pain , tightness , breath
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment use the bottle and the bottle . - gently squeeze the bottle into your neck . - do not break or chew the bottle , as this may affect its contents . - take the bottle out of the bottle before you start using it . - twist the bottle around and gently squeeze it . 5 . - wash your hands . - tilt your head back . - hold the bottle tightly . - pull down the eyelid , which is a small pocket . - press the bottle firmly against the cap
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause the following side effects when taken with ganart ( multi - dose or single - dose ) : very common side effects ( may affect more than 1 in 10 people ) the eye redness . common side effect ( may affects up to 1 in 9 people ) 100 the eye burning , itching , stinging , irritation of the conjunctiva ( the transparent layer at the back of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the surface
keep out of the reach and sight of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . ganf is stable for up to 4 hours at room temperature . do this at all times and do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / ml ) timolol ( 5 mg / l ) timlol maleate ( 6 . 8 mg / kg ). - the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack gan fort is a clear to slightly yellow , colourless to slightly orange solution for injection in the eye
gefitinib mylan contains the active substance gefitinib . this protein is found in cancer cells and is very similar to a natural protein found in the body . gefinib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefinib melan if : you have any other lung problems . some lung problems may be serious . gefnitinib yourlan may cause problems with your liver . gifitin ib mylan is not recommended for use in children under 18 years of age . other medicines and gefidinib tell your doctor if you take , have recently taken or might take any other
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 250 mg antacids taken once daily on an empty stomach ( see section 2 , " gefitinib mylan contains lactose "). if you have trouble swallowing the tablets , or if you take any other liquids , contact your doctor . the usual dose is 20 mg gefinitinib melan once daily . if you forget to take gefitoninib this medicine is for oral use . if it is less than 12 hours until your
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs ( called ' interstitial lung disease '). uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions affecting parts of the
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefginib . - the other ingredients are lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . - in the tablet core are polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what gefnitinib looks like and contents of the pack
reblozyl contains the active substance luspatercept . it is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms include a low red blood cell count ( anaemia ) and red blood infusion . reblozell is used in adults to treat anaemia in adults with mds who cannot be treated with red bloodcell therapies ( erythropoietin therapies ) and in children with beta - thalassaemia . thalAssaemia is a blood
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant , ask your doctor for advice before taking this medicine . if you have thalassaemia ( a condition where the spleen removed ) or have had a blood clot . if your doctor has recommended hormone replacement therapy because of a previous blood clot , preventive measures are needed . medicines to prevent a blood clot from forming in high blood pressure , your doctor may decide to stop rebluzyl . your doctor will check your blood pressure before
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests to make sure that you are fully protected from reblozyl . rebloxyl is given as an injection under the skin . the injections should be given in a maximum of 1 . 0 ml of body weight . your dose will be adjusted by your doctor depending on your blood pressure . use in children and adolescents rebl ozyl is used in adults with myelodysplastic syndromes . the maximum single dose is 1 . 75 ml of solution for
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you have : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or in other parts of the body , blurred vision , which may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions , including rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 24 hours at 2 8 . do away with any unused medicinal product or waste material . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what reblozyl contains - the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg luspaterscept . after reconstitution , each mlof solution contains 50 mg lsuspatercept ( as excipients ). - the other ingredients are citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for pct and ph adjustment ). what rebl ozyl looks like and contents of the pack rebloxyl is a white to off - white powder . reblosyl 25 mg /
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tiv ozanib works by stopping the growth of the cancer . it stops the growth and spread of cancer cells by blocking their growth and division . it also prevents the formation of new blood vessels . fotivd is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to control your disease .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have been told that you have a problem with your st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking fotifda if any of these apply to you . high blood pressure tell your doctor if you think any of this applies to you , or if you notice any change in your blood pressure . fotibda can raise your blood
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of fotivda is 1340 mg once a day for 21 days ( 7 days ). you will take 1 capsule of capsules once a morning for 4 days . your doctor may decide to reduce the dose of the medicine if you take more fotvda than you should if you have unacceptable side effects or if you experience severe side effects after fotrevda therapy . the usual dose of each fotidda capsule is 890 mg once daily for 21
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure ( the most common side effect ) can occur ( see section 2 " warnings and precautions "). tell your doctor immediately if you have high blood blood pressure . symptoms may include severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may want to monitor your blood pressure more closely while you are taking fotivda . high blood hypertension may be increased when you take a medicine to treat your high bloodpressure . if you take more f
what fotivda contains the active substance of fotovda is tivozanib . each tablet contains 890 mg of tivzanib ( as tiv ozanib hydrochloride monohydrate ). the other ingredients are : tablet core : 890 , tivosanib , mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( for strong ammonia solution ) and titanium dioxide in the solvent ( e 171 ). tartrazine aluminium lake ( e133 ) printing ink
what stribild is stribil contains the active substances elvitegravir ( an antiretroviral medicine ) and an integrase inhibitor cobicistat ( a booster ( pharmacokinetic enhancer ) of the active substance elvitesgravira emtricitabine ( an antiprotrovir medicine known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil ( an antitroviral medication known as an nucleotide reverse transcriptases inhibitor ) stribald is given as a single tablet regimen for the treatment of human immunod
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). if you have had treatment with any medicine containing tenofovexil . if your kidney function is not controlled with these medicines . if you take alfuzosin ( used to treat an enlarged prostate gland ) or amiodarone , quinidine ( used for irregular heartbeats ) 47 dabigatran ( used in
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults and adolescents 12 to less than 18 years of age 35 take your medicine at the same time each day . swallow the tablets whole with some water . you can take your tablet with or without food . you may take your tablets with or just after food . your doctor may change the dose of your medicine or interrupt the treatment if necessary . if you take medicines containing oral supplements ( such as antacids , laxatives containing minerals , magnesium , aluminium , calcium , iron , zinc
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is important to avoid unwanted effects . stribild does not cure the hla - b * 5701 virus , but it can cause serious side effects . tell your doctor immediately if you experience any of the following : lactic acidosis ( excess lacticacid in the
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtracitabINE and 245 mg tenofnovir disaproxil ( as mesilate ). each tablet contains 300 mg ten ofovirdisoproxel fumarate and 136 mg tenulfovir . the other ingredients are croscarmellose sodium , hydroxypropyl cellul
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment .
do not take zyprexa if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include a rash , itching , a swollen face , swollen lips and shortness of breath . if you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). if any of these apply to you , tell your doctor before taking zyprixa . warnings and precautions talk to your doctor or pharmacist before taking any of zypoxa . if any part of the medicine is affected
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyprexa tablets should be taken with or without food . zkyprexa can be taken in doses of 5 mg or 20 mg . your doctor may adjust your dose depending on your symptoms . swallow the tablets whole with water . zzyprexa may be taken at the same time each day . you can take your zypitxa tablets with or with food . you should take your tablets at the usual times . zhyprexa coated tablets should not be swallowed whole . swallow your tablets whole
like all medicines , this medicine can cause side effects , although not everybody gets them . unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue . this may be a sign of blood clots in the veins . this side effect may affect more than 1 in 100 people . especially in the legs , symptoms include swelling , pain , and redness in the leg . this can travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately . fever , faster breathing , sweating , muscle stiffness and drowsiness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . zyprexa should not be used after the first month . do this because the expiratory date refers back to the calendar printed on the blister and the blister after that . zysprexa is for single use only . do away with any unused medicine after this period . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use
what zyprexa contains - the active substance is olanzapine . each zyprixa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg . - the other ingredients are tablet core : tablet core ( tablet core ): tablet core , tablet core ; tablet coating : tablet coating ( tablet coat : tablet coat ): tablet coating , tablet coating ; tablet core - lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zy
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein that is produced in the body . it is used to prevent bone loss in adult patients with osteoporosis when treatment with prolia has failed . prolia helps to make bone stronger and keeps it free of the build - up of oestrogen ( a substance that makes bones thin and fragile ). in osteopORosis , osteoporeosis is caused by the lack of testosterone and glucocorticoids . osteopoosis has symptoms such as breaking bones , especially of the spine
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ) if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think you may have a skin infection , tell your doctor straight away . symptoms include a swollen , red area of skin , usually in the leg , which feels hot and tender . if this happens , tell the doctor straightaway . if it happens , call your doctor right away . if your doctor thinks you may be suffering from cellul
what prolia is prolia contains one pre - filled syringe of 60 ml . it is given to you by your doctor or nurse , as a single injection under the skin ( subcutaneous ) in the thighs , abdomen or upper arm . prolia can be used with or without stickers . you can also give prolia with calcium and vitamin d supplements . how prolia works prolia should be injected by your healthcare professional . how much prolia to use prolia will be injected under the supervision of a doctor or a nurse . it will be given to your doctor , nurse or pharmacist . if you have any questions about
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and see a doctor straight away if you develop skin infections ( cellulitis ). if you have any of these symptoms while taking prolium : - swollen , red area of skin , usually in the leg , which feels hot and tender . - symptoms of fever ( see section 2 ). if any of the above apply to you , tell your doctor straightaway . if you get any of them while taking this medicine , tell the doctor straight off . if any other symptoms occur while taking the medicine , please tell your physician . if they do
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . keep the vial in the outer carton in order to protect from light . your pre - filled syringe may be stored at room temperature ( up to 25 ) for a single period of up to three months . after the injection , it may be kept at room temperatures ( up or down ) below 25 for a maximum period of not exceeding 30 days . do this as your doctor or pharmacist will
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg or 60 mg of denosumaab . - the other ingredients are 60 mg acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirux is a vaccine for adults and adolescents from 1 to 15 years of age . it is used to treat two diseases : hepatitis a and hepatitis b : infection with the hepatitis a virus . the liver is swollen and inflamed with the virus . ambirax can be given to people who have the virus in their faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . if you feel sick , have a fever , aches and pains , feel very tired , dark urine , pale faececes or yellowish skin or eyes ( jaundice ). the severity
do not use ambirix if you are allergic to ambirax or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath , swelling of your face or tongue . signs of such an allergic response may occur with any vaccine . if you have hepatitis a or hepatitis b diseases , tell your doctor straight away . if a severe infection with a high temperature has been reported , the vaccine should be stopped . if any of these apply to you , tell the doctor straightaway . if your doctor thinks you may have a minor infection such as a
your doctor or nurse will give you ambirix as an injection into a muscle in the upper arm . ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be completed within 12 months . if you miss an injection , make another one as soon as possible . if it is more than six months since the missed one , make a second one as early as possible and then make another as soon thereafter . if the missed two doses are more than 6 and 12 months after the missed dose , make an extra appointment to make another appointment
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired irritable pain and redness where the
what ambirix contains 26 the active substance is hepatitis a virus . 1 ml solution contains 720 micrograms of elisa units ( mrc ) of hepatitis b surface antigen ( mtr ) ( equivalent to 20 microgram ) of human diploid ( mcr ) cells . the other ingredients are aluminium hydroxide , hydrated in 0 . 05 ml , saccharomyces cerevisiae , aluminium phosphate in 0. 4 ml , sodium chloride and water for injections . what ambirax looks like and contents of the pack suspension for injection in a pre - filled syringe is a white , slightly milky liquid
what bexsero is bexero is a meningococcal group b vaccine . what bex sero is used for bex serumo is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria are important in preventing infections ( such as meningitis , inflammation of the brain and spinal cord ) and in preventing sepsis ( blood poisoning ). the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease .
do not use bexsero if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using bexero if : you have a severe infection with a high temperature . vaccination may be delayed if you have had a minor infection such as a cold . your doctor may postpone the vaccination if : your doctor has a history of haemophilia . you have any other problem that may prevent your blood from clotting properly . you are taking blood thinners ( anticoagulants ) as part of treatment for the immune system ( e
your doctor or nurse will give you bexsero at the recommended dose . the recommended injection is 5 ml in the muscle of the thigh or upper arm . injections will be given every 2 weeks . the interval between injections will last between 2 and 5 weeks . three injections will give the vaccine . an additional injection ( booster ) will be administered . the first injection will be made at 2 - 8 weeks . your doctor will decide on the intervalbetween injections . this interval will last approximately 1 month . the intervals between injections should last between 1 month and 2 months . injections the vaccine will be injected with an additionaljection ( booster ). each
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and see a doctor straight away if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness at the area of injection at the time of injection injection site if any of these side effects occur , stop using this vaccine and tell your doctor straightaway . common ( might affect up to 1 in every 10 people )
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 and 50 micrograms recombinant nisseria maningitis group b noada protein 1 and 2 , 2 and 3 50 microgene ( nhb ) recombinant neoisseria meingitinidis groupb fhbp fusion protein 2 and 2 and three 50 microgamene ( hbf ) produced by recombinant dna technology . the other ingredients are : neissia meningitsidis group a fhba fhp fusion
nitisinone mdk contains the active substance nitisinONE . this medicine is used to treat a rare disease called hereditary tyrosinemia ( hdk ) in adults , adolescents and children aged 1 year and above . in this disease your body does not produce enough of the amino acid tyrosine ( amino acids are substances that are naturally present in the body ). nitisinnone works by reducing the amount of tyrosrine in the blood and reducing the harmful substances that can be present in this medicine . tyrosate is a substance that is naturally present on the surface of the body . low tyrosin
do not take nitisinone mdk if you are allergic to nitisine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitis inone md k is not recommended for use in children and adolescents . your doctor will check your eyes regularly during nitisidone treatment . if you develop red eyes or if your eyes get darker , tell your doctor immediately . your physician may recommend an eye examination . if any of these apply to you , tell the doctor . eye problems due to inadequate diet and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will determine the dose of this medicine to be taken and will determine how long you should continue treatment . the dose that is taken depends on the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg for every kg of body weight taken orally once a day ( 20 mg daily ). in this patient population , the dose may be reduced by taking the capsules with a small amount of water or formula diet . if you take more nitisinone mdk
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 2 8 . do away with the capsules if you notice a temperature not above 25 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nitisinone mdk contains the active substance is nitisinnone . nitis inone mdks 2 mg : each hard capsule contains 2 mg nitisine . nisinone dk 5 mg : one hard capsule releases 5 mg nisine . each hard capsules releases 10 mg nitesinone . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), shellac glaze and nitisginone . what nitishinone mdku looks like and contents of the pack nitisinetone mdky capsules are white to off - white , approximately 15 .
docetaxel accord contains the active substance docetaxell . docetxel belongs to a group of anti - cancer medicines called taxoids . doceteaxel accord is used in the treatment of breast cancer , lung cancer , non - small cell lung cancer ( prostate cancer ), gastric cancer and head and neck cancer . in the treated adult patients with advanced breast cancer the combination of docetixel with doxorubicin , trastuzumab or capecitabine is used to treat early breast cancer with or without lymph node involvement . in combination with docetoxel with either do
do not use docetaxel accord if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) if you have a low number of white blood cells if you suffer from a severe liver disease . warnings and precautions before you are given docetAXel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacord . white blood cell disturbances may occur . if you experience fever or infections , tell your doctor immediately . abdominal pain , tenderness , diarrhoea , rectal
docetaxel accord will be given to you by a doctor or nurse . the dose will depend on your weight and your general condition . method and route of administration docetaxell accord will usually be given as an infusion into one of your veins . the infusion will last approximately one hour . frequency of administration you will usually have your infusion once every 3 weeks . your doctor will take your blood tests periodically to check for changes in your generalcondition . docetxel accord may be given in the presence of diarrhoea , sores in the mouth , numbness , pins and needles , fever , and 63 if you have
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most serious adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells ( alopecia ), nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel and docetxel accord may be increased when other chemotherapeutic agents are given . during the infusion , allergic reactions ( may affect up to 1 in 10
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . store below 25 . do away with the vial and any remaining solution after dilution . the medicine should be transferred from the infusion bag to the infusion vial within 6 hours ( corresponding to 25 hours of infusion ). the infusion solution should be used immediately . non - pvc bags may be stored for 48 hours ( equivalent to 2 hours ) or up to 8 hours . do this to
what docetaxel accord contains - the active substance is docetxel . each ml of concentrate for solution for infusion contains 20 mg docetex . each 1 ml of concentrated concentrate contains 20mg docetoxel . every 4 ml of the concentrate contains 80 mg docel . the 8 ml of solution for injection contains 160 mg docotaxel . - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetacord contains ethanol "), citric acid anhydrated ( see " docel accord contain ethanol "). what docetAXel accord looks like and
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . this medication is used to treat impulsive , hyperactive adults . this type of behaviour is called ' attention deficiency hyperactivity disorder ' ( adhd ). it is used in combination with current stimulant medication to treat adhd symptoms . the medicine is used as a treatment programme in adults , adolescents and children aged 12 years and older who are undergoing psychological therapy , educational therapy and social therapy . intuniv is used 38 in adults with adhd . adhd is not a cure for adhd ; it is
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking intunifililil if you have low or high blood pressure . if you suffer from heart problems . if any of these apply to you , tell your doctor . if your doctor has told you that you have heart problems , tell the doctor . you have fainted recently or had thoughts or feelings of suicide . if this applies to you or you are not sure , talk to the doctor or nurse before taking this medicine
your treatment will be started by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will work out the dose that is right for you . your treatment will usually start with 1 tablet once daily . your dose will be gradually increased over the course of 1 day . the dose may be adjusted to your individual needs . your daily dose will depend on your weight and your general condition . the usual starting dose is 0 . 05 mg / kg bodyweight once
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , stop taking your medicine and seek medical help immediately . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : feeling drowsy ( feeling dizzy ) hypotension ( slow heart beat ( bradycardia ) feeling faint ( loss of concentration ) syncope ( a serious withdrawal side effect from high blood pressure ) symptoms include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). if you get any of these side effects during treatment ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister pack and the carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the tablets should be used within the first week of opening the blisterpack . do this by referring to the new expiry calendar printed on the cartons . do away with the tablets if you notice any change in the appearance of the tablets . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines
what intuniv contains - the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg guanFacine . each extended - release dose contains 2 mg guinfacine . the prolonged - releases of 3 mg guanofacine are followed by 3 mg of guanfuine . every extended -release dose contains 4 mg guaconfacine and the prolonged release dose is followed by 4 mg of Guanfacin . - the other ingredients are hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , p
ecalta contains the active substance anidulafungin . ecalta is used in adults and adolescents ( aged 1 to 18 years ) to treat adults with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . the infection is caused by the growth of fungo - related fungal cells called candida . ecalda contains a substance called echinocandins . these medicines are used to treat serious fungal infections caused by fungal cell walls . ecALTa is indicated in adults because it is thought that fungal types have incomplete or defective cell walls , which may
do not use ecalta if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using ecaltra if you have liver function problems . your doctor may decide to reduce your dose or stop your treatment with anaesthetics . your treatment may need to be delayed or stopped . if you think you may have an allergic reaction , tell your doctor straight away . if this happens , tell the doctor immediately . itching , wheezing
the treatment will be given to you by a doctor or nurse . the recommended dose is 200 mg or 100 mg given once a week . the dose is 1 dose ( 0 . 5 ml ) per kg body weight . the doctor will calculate the patient ' s weight based on the patient '. the recommended starting dose is : 1 dose for adults aged 18 years and older : 3 . 0 ml . the starting dose for children aged 200 mg and 1 . 5ml is 100 mg . the patient will be weighed by a healthcare professional . the amount of ecalta given will be calculated by your doctor based on your weight . ecaltva
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . ecalta can cause serious sideeffects , including convulsion ( seizure ), flushing , rash , pruritis , itching , hot flush , hives , sudden contraction of the muscles , wheezed or coughing , difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): low blood potassium ( hypokalaemia ), diarrhoea ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution may be stored for up to 24 hours at 2 - 8 . the infusion solution may either be stored at 25 for up or 48 hours at 25 or 48 for up and 48 hours . do away with the vials and vial after this period . do throw away any medicines via
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of aniduafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid 30 what ecaltas looks like and contents of the pack ecaltfa is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is a substitute for pegylated human coagulation factor viii . the human coaggulation factor iii is a copy of factor v ii produced by the human body . factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is not produced in the body . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older with haemaophilia b , an inherited bleeding disorder caused by lack
do not use adynovi if you are allergic to rurioctocog alfa pegol or octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using adynov if you have had an anaphylactic reaction ( a severe , sudden allergic reaction to any ingredient of adyno ). allergic reactions may include rash , 95 hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing ,
treatment with adynovi will be started by a doctor with experience in the treatment of haemophilia . adynov is used for treatment of bleeding in adults . adnovi is used as the replacement therapy for adynocid . adenovi is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . how much adynvo to use the usual dose is 40 mg once a day . your doctor may increase your dose to 50 mg once every 2 weeks depending on the severity of bleeding . how adynviet is given your
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur after the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath or fainting occur , prompt emergency treatment is recommended . previous treatment with factor viii ( more than 150 days of treatment ) inhibitor antibodies ( see section 2 ) have been
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a maximum period of 3 days . do this medicine if it is stored at a temperature not above 30 for a single period of no more than 3 days , but within this period the
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu of ruricoctocag alfapegol . the solvent vial is provided with 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) aminomethane , polys
rekovelle contains follitropin delta , a follicle stimulating hormone . it belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . they are produced by the ovaries and are involved with the development of many egg sacs .
do not use this medicine if any of the above applies to you . if you are not sure , talk to your doctor or pharmacist before using rekovelle . warnings and precautions talk to the doctor or nurse before using this medicine : if you have : - a tumour in your uterus , ovaries , breasts , pituitary gland or hypothalamus - enlarged ovaries - cysts on your ovaries ( polycystic ovarian disease ) - bleeding from the vagina ( an early menopause ) - malformations of the sexual organs ( a condition that can occur during pregnancy ) - fibroids of the uterus
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given to you by your doctor during your first treatment cycle . your doctor will prescribe a type of anti - müllerian hormone that stimulates your ovaries to produce stimulation with gonadotropins . the dose will depend on your blood weight and on your body weight . your physician will take a blood sample during the last 12 months to check how well your medicine is working . the duration of treatment depends on your doctor ' s opinion on your condition and on the amount
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones ( infertility ) this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort and swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . these symptoms are usually mild to moderate and generally disappear within a few days . a side effect that may affect up to 1 in 10 people is headache . nausea ( ovarianhyperstimulation sensation ) pelvic pain and discomfort ( ovarian origin tiredness and fatigue ) common ( may affect 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 for a single period of 3 days . after this period , the product may be stored for up to 3 days at 28 or 25 . do away with the treatment any unused solution must be discarded . do this in accordance with local requirements for medicines .
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 mg of the active ingredient follitrotin deltain each millilitere of solution ( corresponding to 12 mg follitruin delta per ml ). - the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates , concentrated phosphoric acid , sodium
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revminty elliptone contains flutic asone fuboate and 92 mg vilancerol . the 22 mg / 22 mg inhalation dose of fluticusone fubeate and 184 mg vilterol is equivalent to 92 / 22 . for chronic obstructive pulmonary disease ( copd ) in adults , the usual dose of asthma is 12 inhalations ( 184 mg / 42 mg ) once a day . for asthma in adults and adolescents 12 years of age and older ,
do not take revinty ellipta if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ellipta . ellipta has been shown to increase the risk of liver disease . the following side effects have been reported with ellipta : moderate or severe liver disease , the lower strength of revintchy ellipta 92 / 22 mg / ml . if you have heart problems , high blood pressure , tuberculosis ( tb ) of the lung , or any long standing or untreated
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the recommended dose for asthma is one inhalation twice a day ( one inhalations of fluticasone furoate and 22 mg vilanterol ) once a day . for severe asthma , the higher strength inhalation is one of flitantasonefuroate ( 22 mg and 22mg vilancerol ) twice a daily . for copd the recommended starting dose for copdi is one and a half inhalations ( one and one inhalants of fl
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta have been reported in rare cases ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling mainly of the face and mouth ( angioedema ), feeling very wheezy , coughing , difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness immediate breathing difficulties immediate breathing difficulty stop taking revinty ellipta and contact a doctor
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each inhalation provides 92 micrograms of flutic asone fubate and 22 microgram of vilanerol ( as trifenatate ). each 184 microgram inhalation delivers 184 microgms of flilitasonefuroate , 22 microramb of vilterol (as trifnatate ) and 184 microrambi of vicenatine . the other ingredients are lactose monohydrate ( see section 2 " revintchy ellipta is for
atripla contains three active substances used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , a nucleosiderase reverse transcriptases inhibitor ( tnrtis ), tenofovir , aucleotide reverse transcript enzyme ( ntrti ). these active substances are used in combination with antiretroviral medicines to reverse transcriptome ( reverse transcriptate ) change the way the virus is expressed . atriplas is a treatment for human immunosupp
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach ( see section 1 , " important information about food and drink " and section 2 , " possible side effects "). some side effects may be more common ( dizziness and drowsiness ). if you take more atripola than you should if you have taken more atrippla than your doctor has recommended , contact your doctor . if you forget to
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and seek medical help immediately :
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripera film - coated tablet contains 600 mg eflavirenz and 200 mg emtracitabINE and 245 mg tenofvir disopicroxil ( as fumarate ). the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atriplea contains sodium "). the tablet film coating
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin . the natural gonadonotrophins releasing hormone ( gnrh ) is produced by biotechnology in the laboratory . when the release of gonadotroprophins from the follicle stimulating hormone is made , gonadots help to control the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . orgalutra helps release the immature egg cells from the sacs and follicles from the ovary . orgalin
do not use orgalutran if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be hypersensitive to gonadotrophin releasing hormone ( gnrh ) or any other gonadoteh , a gnrh analogue . if you have a moderate or severe kidney or liver disease . if any of these apply to you , tell your doctor . if your doctor thinks you may have been pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions . if this applies to you ( or you
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . orgalutran is intended for use in women who are undergoing the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( corifollitropin ) on day 2 or day 3 of each cycle . orgdalutran should be injected under the skin ( subcutaneously ) every 5 to 6 weeks . orgalinutran must not be used in combination with fsh . the preparations are given
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect more than 1 in 10 people is local skin reactions ( redness and swelling ). the local reaction usually disappears within 4 hours . this is uncommon ( may affect up to 1 in 100 people ). other side effects are headache , nausea , malaise . this rare ( may effect up to one in 10 , 000 people ) allergic reactions are rash facial swelling difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat that may cause difficulty in breathing or swallowing ( angioedema
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe after exp . the exp date refers to the last day of that month . syringes should be clear , solvent - free solutions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol and water for injections ( see section 2 ). - the ph is sodium hydroxide and acetic acids . what orgalustran looks like and contents of the pack orgaluitran is a clear , colourless aqueous solution for injection . the solution is clear and colourless . it is supplied in a glass vial for subcutaneous administration . the needle is inserted into the vial . the solvent is dry natural rubber
what blitzima is blitzima contains the active substance rituximab , a " monoclonal antibody ". it attaches to a specific type of white blood cell called " b - lymphocyte ". when ritukimab sticks to the b - locyte surface , it stops the cell from growing and dividing . what blitzima looks like and contents of the pack blitzima has been given to you by your doctor to treat : a ) non - hodgkin ' s lymphoma this is a disease of the lymph tissue that affects the immune system . it affects a type of small white blood type called b -
do not use blitzima if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure . if severe uncontrolled heart disease . warnings and precautions talk to your doctor or pharmacist before using blitzima : if you know that you are at risk of getting hepatitis b . if any of these apply to you , tell your doctor before using this medicine . if this applies to
your doctor will decide how much blitzima you will receive and how often you will be given this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . you will usually receive this medicine as a drip ( intravenous infusion ). your doctor will prescribe you medicines for each blitzima administration . you may also be given blitzima together with other medicines ( pre - medication ) to reduce the risk of side effects . your treatment will be repeated every three weeks . if you have non - hodgkin ' s
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains - the active substance is rituximab . each ml of solution contains 10 mg or 100 mg of ritukimab ( as 10 mg ). each 50 ml vial contains 500 mg of the active ingredient ritudimab in 10 mg . - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is supplied in 2 ml glass vials , each containing 50 ml . pack size of 1 v
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body ) that attaches to a specific target in the brain . this target is found in the outer layer of the body and helps to reduce the inflammation in your body . roactemrea is used to treat symptoms such as pain and swelling in your joints . roactoremra reduces the damage to the cartilage and bone in the joints caused by the disease . roactsemra is used in adults with moderate to severe active rheumatoid arthritis ( an autoimmune disease ) who have not received
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . during the infusion with roactema , you may experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips and skin rash . during and after the infusion , you should tell your doctor if you develop any signs of infection or infections . tell your physician immediately if you feel unwell . roacterera may affect your body ' s ability to fight infections
the doctor or nurse will give you roactemra by injection into a vein ( intravenous infusion ). your doctor or a nurse will decide on the intravenous infusion you need and will decide how long you should receive the treatment . the recommended dose of roactema is 8 mg per kg body weight . the usual dose is 4 mg per kilogram body weight each day . the dose of the first dose is 8 micrograms per kg of body weight every day . your doctor will decide the dose that is right for you . the second dose is 30 microgram per kg or 12 microgram / kg bodyweight each day
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in patients treated with roactamra : common ( may affect up to 1 in 10 people ): allergic reactions , difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , which may travel through the mouth and skin blisters and stomach ache signs and symptoms of liver toxicity . uncommon ( may effect up to1 in 1000 people ): tiredness , abdominal pain , j
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains - the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 ml . each 10 ml vials contains 200 mg of of tocelizumumab ( 20 mg / 20 ml ). each 20 ml vray contains 400 mg of the active substances of tocizumb ( 20mg / 20ml ). - the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like
what onbrez breezhaler is onbreezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it works by relaxing the muscles in the walls of the small air passages in the lungs . what onbrezer is used for onbrezezhalzer is prescribed for adults to help relieve breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd causes the muscles around the airways to relax , making breathing difficult . this medicine works by helping relax these muscles in your lungs .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is not controlled with onbreez breez inhaler . - if any of these apply to you . warnings and precautions talk to your doctor or pharmacist before using onbrezer breezzer . - tell your doctor immediately if you get tightness of the chest , coughing , wheezing or breathlessness immediately after using the medicine . - this may be a sign of a condition called bronchospasm . tell your physician immediately
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the usual dose is one 150 microgram capsule twice a day . your doctor may increase your dose to 300 micrograms once a day depending on how you respond to the treatment . you should use your inhaler at least 24 hours after you last used it . onbrez breezhaler is supplied as an inhaler and capsules ( in blisters ) containing the medicine ( inhalation powder ). the onbreez breez inhaler is provided in a pack containing one inhal
what onbrez breezhaler contains - each onbreez breez inhaler 150 mg hard capsule contains 150 mg indacaterol ( as indacathol maleate ). - the other ingredients are lactose and the capsule contains gelatin . - eachonbrez bronzhalER 300 mg hard capsules contains 300 mg indiacaterol . - the ingredients are indacataterol maleates , lactose , the capsule also contains gelatin and an inhaler . capsules are provided in blisters . the capsules are supplied with a white powder . - onbrezy breezeler 150mg hard capsules contain
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( a condition which can lead to stroke , heart attack ,
do not take clopidogrel hcs - if you are allergic to clopiperrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking clopridogrel ccs . warnings and precautions talk to you doctor or nurse before taking any of your medicines : - if : you have an increased risk of bleeding - if this
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day with food . if you have a condition called ' atrial fibrillation ' ( an irregular heartbeat ), your doctor may prescribe a lower dose ( up to 75 mg of clopidogrel hcs per day ) to help you relieve severe chest pain ( unstable angina or heart attack ). the recommended starting dose is 300 mg of one tablet of clubidogl hcs ( two tablets of 75 mg ) once a week
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), which may cause bleeding mainly under the skin ( red pinpoint dots and /or confusion ), which can be severe ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopigrel ( as hydrochloride ). the other ingredients are ( see section 2 " clopidaogrel hexamyl "): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil . tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogl
febcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that you have not previously been treated with other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have had a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ). if severe skin peeling and swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing has been reported with fetcroj . if any allergic reaction occurs to other antibiotics , tell your doctor . warnings and precautions talk to your doctor or pharmacist
this medicine is given by a doctor or nurse as an infusion ( a drip ) into a vein . it will take about 3 hours . you will usually receive 2 doses of fetcroja treatment . your doctor will check your infection and relieve any pain during the fetcroJA infusion . your dose of fetroja will be given by your doctor or by infusion into a separate vein . if you have kidney problems tell your doctor . if your doctor thinks you may be at higher risk of kidney problems , your dose may be reduced . if this happens , your doctor may decide to increase your dose . if possible , your next dose of f
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : - severe allergic reaction ( sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions with difficulty swallowing or breathing ). this reaction may be accompanied by diarrhoea , stools , blood or mucus . treatment with medicines to slow bowel movement may be necessary . other possible side effects if you get any of these side effects talk to your doctor or pharmacist . the following side
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefingerocol . - the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojoe is a white to off - white powder for solution for infusion . it is supplied in packs of 10 vials .
depocyte is used to treat adults with lymphomatous meningitis . lymphomatinous meneningitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte is a type of medicine that works by blocking the growth of lymphoma tumour cell cells .
do not use depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a meningeal infection . warnings and precautions severe neurological side effects have been reported with depocyte . symptoms of the nervous system include convulsions , pain , numbness , tingling , blindness and visual disturbances . if you experience any of these symptoms , stop taking depocyte and contact your doctor immediately . if any dexamethasone tablets are used , tell your doctor . unwanted effects your doctor will monitor your side effects and tell you if you
treatment of cancer in the lumber sac will be overseen by a doctor who is experienced in the care of patients with advanced stage of cancer . depocyte will be given to you by a qualified healthcare professional in a hospital or clinic . depocytes will be prepared and given to your child by a healthcare professional . the recommended dose is one vial of depocyte per day . the dose will be calculated by your child ' s doctor based on the size of the sac . the doctor will decide the correct dose based on any side effects that may be expected from depocyte . the usual dose is based on body temperature ( up to 22 ) and
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may occur with your treatment : very common side effects ( may affect more than 1 in 10 people ): common ( may affects up to 1 in 100 people ): uncommon ( may affecting up to1 in 10 , 000 people ): very common ( might affect up to one in 10, 000 people ) very rare ( may effect up to a maximum of 1 in 1000 , 000 , 000 or 1 in every 10 ,000 people ): not known ( frequency cannot be estimated from the available data ): frequency cannot yet be estimated based on the available
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . depocyte should be stored in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . after dilution , depocyte may be stored for up to 4 hours at 2 - 10 . do this if you notice that the solution is discoloured or has a changed appearance . do away with the container and dispose of depocyte in accordance
what depocyte contains - the active substance is cytarabine . one ml of suspension contains 10 mg cytarbine . each vial of depocyte 5 ml solution contains 50 mg cytabine ( as cholesterol , triolein ), dioleoylphosphatidylcholine , dipalmitoylophosphatidoylglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a clear , colourless solution for injection . depocyte can be supplied in a pack of 5 ml vials as a single injection or in a
what bemrist breezhaler is bemist breez inhaler contains two active substances called indacaterol and mometasone furoate . indacasterol belongs to a group of medicines called bronchodilators . it works by relaxing the muscles in the lungs , making it easier for air to get in and out of the lungs . mometsone fruate belongs to the group of medications called corticosteroids . corticostromes reduce the swelling and irritation ( inflammation ) in the small airways in the lung , which can lead to breathing problems . cortics reduce
do not take bemrist breezhaler if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have heart problems . if your doctor has told you that you have an irregular or fast heartbeat . if any of these apply to you , tell your doctor . if this applies to you . if the doctor has advised you that your dose may need to be adjusted . if if you suffer from thyroid gland problems . warnings and precautions talk to your doctor
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . bemrist breezhaler capsules should be swallowed whole with water . swallow the capsules whole with a glass of water . do not chew or crush the capsules . the medicine should be inhaled immediately after you have finished using it . if your asthma does not improve or your symptoms get worse , your doctor may prescribe bemrid breez inhaler . be bemist breezhhaler is for inhalation use only . you should use it with an inhaler and
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . tell your doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( may affects up to 1 in 100 people ): swelling of your tongue , the lips , face or throat ( angioedema ). other side effects other side side effects include the following side effects : common ( might affect up to1 in 10 , 000
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . the capsules should be kept in the original blister in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . bemist breez inhaler 125 micrograms / 62 . 5 microgram inhaled in a single inhalation each nostril contains 173 microgram indacate . each capsule contains 150 microgram of indacataterol and 80 microgram mometsone furate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 125 microgig indacatedol and 62 . 3 microgramm mometsaone
the active substance of zyllt is clopidogrel . it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zylltic is used to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( a condition which can lead to stroke , heart attack , or death ). zll
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . warnings and precautions talk to your doctor or pharmacist before taking zylltt if any of these apply to you . if any part of the following apply to your situation , tell your doctor before taking the medicine : if you think any of this applies to you , tell the doctor before you take zllt . if your
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day with food . if you have a condition called ' atrial fibrillation ' ( an irregular heartbeat ), your doctor may prescribe a lower dose ( one 75 mg tablet of zyllt ) to be taken once a week . if severe chest pain ( unstable angina or heart attack ), your dose may be increased to 300 mg of zllt once a daily . this will be given as 75 mg once a morning . your doctor will
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), which may be associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains - the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). - the other ingredients are lactose ( see section 2 under ' zyllts contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what zyllT looks like
lamivudine teva contains the active substance lamivudrine . lamivudaine tella is used to treat long term ( chronic ) hepatitis b infection in adults . lamibudineteva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic " infection can lead to liver damage . lamlivudine teneva works by reducing the amount of hepatitis b in your liver , and so reduces the risk
do not take lamivudine teva - if you are allergic to lamivuine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamividine tevas may be taken with other similar medicines . serious side effects if you have liver disease ( hepatitis c . if you become overweight , your doctor may need to change your dose ). your doctor will do blood tests before you start your medication . see section 4 for more information . warnings and risks talk to your doctor before taking lamivodine teeva . your hepatitis may get worse if you take lamvudine .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor will prescribe the best dose for you . your dose will depend on your condition and on your doctor ' s response to lamivudine teva . your physician will prescribe a dose that is right for you and will work with you . if you have problems with your hepatitis b infection , your doctor may prescribe lamivudaine with another medicine . if your doctor thinks that lamivuine is not suitable for you in the treatment of hiv infection
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in clinical trials for other conditions linked to hepatitis b . the most frequently reported side effects during therapy for hepatitis b are listed below . the frequency of side effects listed below has been determined by the following clinical trials : tiredness respiratory tract infections throat discomfort headache stomach discomfort pain nausea vomiting diarrhoea increases in liver enzymes ( seen in tests ) in the muscles allergic reaction ( rare , may affect up to 1 in 1 , 000 people ) swelling of eyelids , face or lips ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivu . each film - coated tablet contains 100 mg of lamivubine . - the other ingredients are microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ) and iron oxide red ( e 172 ). what lamivUDine teeva looks like and contents of the pack orange , biconvex film - coat : 32 lamivuxine tevas
nespo ( an anti - anaemic ) is used to treat your anaemia . anaemia is caused by low levels of red blood cells . the symptoms include fatigue , weakness and shortness of breath . it is caused in part by the lack of the natural hormone erythropoietin . erythroietin works by helping your kidneys to produce more red bloodcells . darbepoetin alfa is used for the treatment of chronic renal failure . symptomatic anaemia can be caused by chronic renalfailure or kidney failure . kidney failure is caused when your kidney does not produce enough of the naturally
do not use nespo if you have high blood pressure or are taking other medicines . if you are allergic to nespos ( darbepoetin alfa ) or r - huepo . if this applies to you , tell your doctor . warnings and precautions talk to your doctor before using nesp if you suffer from high bloodpressure or from medicines used to treat sickle cell anaemia . if your condition is not well controlled , you may experience epileptic fits ( seizures ), convulsions or fits . if any of these apply to you ( or you are not sure ), talk to a doctor
your doctor will carry out blood tests before you start nespo . your haemoglobin level will be checked every 10 weeks . your doctor will check your haema level every 10 to 12 weeks . the pre - filled syringe is intended for injection into a vein ( intravenous ). in patients with chronic renal failure , a single injection is given under the skin into a veins ( intravenously ). your anaemia will be monitored by your doctor . your dose of nespos will depend on your body weight . the usual dose is 0 . 75 mg / kg body weight given once every week . your usual dose will be 0 .
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : 471 common ( may affect up to 10 in 100 people ): high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( may effect up to 1 in 100 , 000 people ): blood clots ( thrombosis ) pain in the area injected rash and redness of the skin rare ( may affects up to one in 10 , 000 users ): serious allergic reactions sudden life - threatening allergic reactions ( anaphylaxis ) swelling of the face , lips , mouth
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep nespos in the original package in order to protect from light . after first opening of your syringe , you may take nesp out of its refrigerator and keep it at room temperature ( not above 30 ) for no longer than 7 days . do this at the end of this 7 - day period . do away
what nespo contains the active substance is darbepoetin alfa . each ml of solution for injection is a pre - filled syringe of 10 ml , 15 ml , 20 ml , 30 ml , 40 ml , 50 ml , 60 ml , 80 ml , 100 ml , 130 ml , 150 ml , 300 ml , 500 ml . the active ingredient darpepoetein ala is produced by recombinant dna technology . the other ingredients of nespos are sodium phosphate monobasic , sodium phosphate dibasic ( e463 ), sodium chloride , polysorbate 80
macugen is a solution for the treatment of macular degeneration in adults . it contains the active substance pegaptanib . this medicine is used to reduce abnormal formation of new blood vessels in the eye . macugen is used for thetreatment of macul degeneration . in this disease , vision loss occurs due to damage to a part of the retina called the macula . macula is the thin layer between the two layers of the eye called the ' amd '. abnormal blood vessels grow in the retina and can affect the macular function . these new blood structures can bleed or leak fluid causing the maculas to bulge ,
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in your eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you have or have ever had an infection or bleeding in the eye , stop using macug injection and contact your doctor immediately . if any of these apply to you , tell your doctor straight away . if your doctor thinks you may have an infection , or bleeding under the eye . if this happens , stop macugen injection immediately and contact a
mugen is given to you by a doctor or nurse . your doctor or pharmacist will give you macugen as a single injection into your eye . adults from 6 months of age and older : the injection will be given into the vitreous part of the eye . your eye doctor will decide how much macugen you need . your dose of antibiotic eye drops will be adjusted by your doctor . your eyes will be treated with some local anaesthetic (umbing medicine ) to reduce any pain you may have after the injection . if you are allergic to antibiotic eyedrops , your doctor may decide to monitor your eye during antibiotic treatment . if
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported following macugen treatment . the symptoms are described in section 2 . if you experience any of these symptoms , contact your doctor immediately . other side effects very common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the medicine should be used immediately . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml solution . - the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch . each pack contains a pre - packed syringe of
what kepivance is kepovance contains the active substance palifermin , which is produced by biotechnology in the plant called escherichia coli . palifermine works by blocking the growth of epithelial cells in the mouth and digestive tract , and by blocking their growth in the tissues of the skin . what kepervance is used for kepvelance is given to adults to treat oral mucositis ( soreness , dryness or inflammation of the mouth ) as a side effect . it is given in combination with treatments to treat your blood cancer . if your blood cancers are not treated with chemotherapy
do not use kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine . children and adolescents kepvelance is not recommended for use in children and teenagers under 18 years of age . other medicines and kepervance tell your doctor if you take , have recently taken or might take any other medicines . kepivalance may be taken with heparin . if you have recently been given heparrin , tell your physician . pregnancy
how kepivance is given the doctor will decide on the dose you will receive . the usual dose of cancer treatment for adults is one 60 mg tablet of kepvance per kilogram body weight . the dose will be given as an intravenous injection into a vein . how kepvelance is used kepovance is usually given to you three days before chemotherapy ( chemotherapy and radiotherapy ) and three days after chemotherapy ( radiotherapy ). you will be treated with chemotherapy andradiotherapy for 24 to 48 hours after the chemotherapy . you will also be given radiotherapy after radiotherapy . if you are given more
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects include skin rash , itching , redness , pruritus and erythaema ( an increase in the thickness in the mouth or tongue , change in colour of the mouth , tongue , generalised swelling , oedema , swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , decrease in lipase and amylase levels , and increased levels of digestive enzymes in the blood . treatment may be interrupted
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepvelance looks like and contents of the pack kepiverance is a white powder supplied in a glass vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcitepine which increases the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . cinaconcet accordpharma is used in adults with secondary hyperparathyroidism ( secondary ) and serious kidney disease who are on dialysis or whose thyroid gland is damaged . cicalcepine is used for the treatment of adults with primary hyperparathroidism when
do not take cinacalcet accordpharma - if you are allergic to cinacealcep or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will check your blood calcium levels regularly while you are taking cinocalcordpharma . warnings and precautions talk to your doctor or pharmacist before taking cicalcut accordphara : - if any of these apply to you , tell your doctor before taking this medicine . - if your doctor has told you that you have a history of seizures (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma should be taken orally with or without food . cinnacalcitpharma can be taken with or shortly after meals . the tablets should be swallowed whole with water . your doctor will take regular blood samples during treatment to monitor the progress of secondary hyperparathyroidism . the usual dose of cinocalcordpharma is 30 mg once a day ( two tablets in the morning and one in the
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches , cramps or seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth , tongue or throat , difficulty in swallowing or breathing ( angioedema ). these side effects are common ( may affect up to 1 in 10 people ) and may include nausea and vomiting . if you notice any of these side effect , contact your physician immediately . common ( might affect up
what cinacalcet accordpharma contains - the active substance is cinocalcep . each film - coated tablet contains 30 mg , 60 mg or 90 mg cinacealcip . - the other ingredients are hydrochloride , cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinaconalcordpharma looks like and contents of the pack cinicet accord ph
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) and metin belongs to the group of substances called biguanides . they work together to lower blood sugar levels in adult patients with diabetes called ' type 2 diabetes mellitus '. this medicine works by replacing the insulin that your body produces . this medicine can be used alone or in combination with certain other medicines used to treat diabetes ( such as sulphonylureas or empagliflo
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have severely reduced kidney function . - if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking jentadoeto . warnings and precautions talk to you doctor or nurse before taking this medicine : - if : you have uncontrolled diabetes ( severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , l
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . jentadueto should be taken with or without food . you should take jentueto either alone or in combination with either currently metformin or individual tablets of linagliptin or metformatin . always take this medication exactly as described in this leaflet or as your pharmacist will tell you . you can take this tablet with or with food . if you have an upset stomach , take 5 mg linaglptin or 2 , 000 mg metforma
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change and confusion . hypoglycemia is a very rare ( may affect up to 1 in 10 , 000 people ) but very serious side effect . jentodueto plus sulphonylurea may cause the combination jentadenueto
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . blister : store in the original package in order to protect from light . do this medicine if you notice that the pack is damaged or shows signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metforman hydrochlorides . - each jentinaduet 2 . 95 mg / 1 , 000 mg film film - coating contains 2. 5 mg linagoptin and 1 , 500 mg met formin hydroxychloride ). - the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica ,
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older who are infected with hiv . edirant belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants is used in adults to treat hiv in adults and adolescents aged 12 months and older , who are also infected with the hiv virus . edrant is not recommended for use in combination with hl medicines . other medicines and
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurent if you : - are taking any of any of , or have recently taken any of : - any of a combination of any combination of the following medicines : carbamazepine , oxcarbazepine or phenobarbital or phenytoin - medicines used to treat some bacterial infections ( such as tuberculosis ) - omeprazole , esomeprazole or lansop
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet a day . adults ( 18 years of age and older ) edurant should be taken with or without food . do not take more than the recommended dosage . do this if you have any questions . do ask your doctor . edurants contains rifabutin . eduant contains an ant ( a medicine used to treat diseases ). the acid in the stomach is made up of aluminium / magnesium hydroxide and calcium carbonate . the
like all medicines , this medicine can cause side effects , although not everybody gets them . headache , nausea , difficulty falling asleep , insomnia , dizziness , and changes in your routine liver tests . increases in transaminase and increase in cholesterol and pancreatic amylase in your blood . abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your bloodstream , triglycerides , lipase and bilirubin in your body uncommon ,
what edurant contains - the active substance is rilpivirine . each tablet contains rilpaline hydrochloride . each edurent contains rrilpivira hydrochlorides equivalent to 25 mg rilpaivirrine . - the film - coated tablet core contains lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . - printing ink : the film coating contains lactosmonohydrate , hypromellose 2910 , 6 mg titanium dioxide ( e
avandamet tablets contain two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes in adults . type 2 diabetic usually develops when your body does not make enough insulin to control the level of sugar in your blood . your doctor will check blood sugar levels regularly , and may change the dose of insulin that you take , whether or not rosigslitazONE and met formin . the insulin that your body makes helps lower your blood sugar . avandamter is also used as a sulphonylurea ( a type of diabetes medicine ) in adults
follow all your doctor ' s instructions carefully . check with your doctor or pharmacist if you are not sure . if you have any questions about your diabetes , ask your doctor . warnings and precautions talk to your doctor , pharmacist or nurse before taking avandamet : if you : - are allergic ( hypersensitive ) to rosiglitazone or metformin ( see section 2 ). - have had a heart attack or severe angina . - have heart failure or have had heart failure in the past . - suffer from severe breathing difficulties . - are suffering from liver disease . - know that you have diabetic keto
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is usually taken once a day . you can take this dose with or without food . you may take it with or just after a meal . you should take it at least 1 hour before or 8 hours after a food or drink . the maximum dose should be taken once daily . you must take it between 4 mg rosciglitrazone ( corresponding to 1000mg metform
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet may include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), with difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamnet and contact your doctor straightaway . lactic acidosis ( build up of lacticacid in the blood ( lactic acidsosis is a common side effect of metformin in patients with severe kidney disease ). symptoms of lact acidosis include rapid breathing , cold stomach pain
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp expiry day refers to the last day of that month . this medicinal product does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do away with the blister and the blister after this period . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets come in different strengths : 1 tablet of rosigllitazon and 500 mg metforma . each tablet contains 2 tablets of rosciglitizone and 500mg metforman . each 2 tablet of oscig litazone plus 1000 mg met formin . each 4 tablet of a tablet of an oscoglitazione and 1000 mg meetformin contains sodium starch glycollate . the other ingredients are hypromellose , microcrystalline cellulose ,
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrel melan is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( a condition which can lead to stroke , heart attack ,
do not take clopidogrel mylan 31 if you are allergic to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you ( or you are in any doubt at all ), consult your doctor before taking clopridogrel melan . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines :
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day with food . if you have a condition called ' atrial fibrillation ' ( an irregular heartbeat ), your doctor may prescribe a lower dose ( up to 75 mg of clopidogrel mylan per day ) to help you relieve severe chest pain ( unstable angina or heart attack ). the recommended starting dose is 300 mg of one tablet of clubidogl mylan ( two tablets at once ) once a week for
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), which may cause bleeding mainly under the skin ( red pinpoint dots and /or confusion ), which can be severe ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopipidogel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 " clopidaogrel melan contains hydrogenatedcastor oil "), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogl
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thrombolocytopenia ), in adults , adolescents and children . it is used as a medical procedure to reduce the risk of bleeding in adult patients . it works by reducing the number of platelets in the blood . platelets are a type of blood cells that are involved in the process of dividing blood and allowing the blood to clot , which reduces the risk and severity of bleeding .
do not use doptelet if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using doptele if you : - have blood clots in your veins or arteries . this is because blood cl clots may increase the risk of blood clotting . - have cancer . - are taking the contraceptive birth control pill or hormone replacement therapy . - recently had surgery or are seriously injured . 23 - are overweight . - suffer from advanced chronic liver disease . children and adolescents dopteel is not recommended
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will calculate your dose based on your body weight and will determine the dose you should take during your procedure . the usual starting dose is 5 mg once a day . this may be increased to 8 mg once daily depending on your response to doptelet . your dose may be adjusted to take doptelets at intervals of 20 , 40 , 60 or more mg once every 5 days . your platelet counts may be reduced . if you take more dopteol than you should if you accidentally take too
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain swelling bone pain muscle aches fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet .
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormboprag maleate equivalent to 20 mg avatrambopg . - the other ingredients are lactose monohydrate ( see section 2 under ' dopteel contains lactose '), microcrystalline cellulose , crospovidone type b [ e110 ], silica , colloidal anhydrous , magnesium stearate . - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by attaching itself to the heart arteries , thus increasing heart rate and helping to relax the muscles of the heart . rapiscan is used for a type of heart scan called ' myocardial perfusion imaging '. the scan uses a radioactive substance called a ' radiopharmaceutical '. these images are taken using a thin needle to insert into the muscles in the heart using a readmill . a scan is taken to measure the amount of radiopharma in the body . it is given into a vein by your hand . images are then taken
do not take rapiscan if you have slow heart rate , high degree heart block , sinus node disease , or a pacemaker . if you experience chest pain ( unstable angina ) during treatment , you should tell your doctor . if your doctor has told you that you have low blood pressure ( hypotension ) or heart failure . if if you are allergic to regadenoson or any of the other ingredients of rapiscin ( listed in section 6 ). warnings and precautions talk to your doctor before taking rapiscen if any of these apply to you . if any or all of the above apply to your situation , talk
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart . the dose will be calculated by your doctor based on blood pressure . the recommended dose is 400 mg given as a 5 ml solution the injection will be administered over a period of 5 to 10 minutes . the usual dose is based on your weight . the doctor will also give you an injection of sodium chloride 9 mg ( 0 . 9 %) solution for injection ( injection of 5 ml ) as a radioactive substance ( radiopharmaceutical ). the dose of rapiscan given will depend on your heart rate and your heart rhythm
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects are usually mild to moderate . the rapiscin injection should be given within 30 minutes of your last meal and should be stopped without any treatment . tell your doctor straight away if you notice any of the following side effects : sudden stopping of the heart , damage to the heart ' s electrical signal , heart block ( a disorder of theheart ' s electrosignal ), rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face , inability to speak . if you have any of these , tell your
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . pde 5 works by helping to relax the blood vessels in your penis . this helps to relax them in your normal position , allowing blood to flow into your penis when you get sexually excited . viagra helps you to get an erection when you are sexually stimulated . viag is a treatment for adult men with erectile dysfunction ( impotence ) that is when a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . if you have previously taken any of these medicines ( see also section " warnings and precautions "). - if any of your patients have angina pectoris ( " chest pain "). if you take any of any of them , including any of those listed in this leaflet . - if the medicines you are using are nitric oxide
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg . you should take viagra twice a day . viagra film - coated tablets are also available as viagra orodispersible tablets . take viag twice a daily . swallow the tablet whole with water . viag can be taken with or without food . viaga can be used if you have an erection , or if you feel sexually stimulated . if you take more viagra than you should if you accidentally take too many tablets , contact your doctor immediately . if possible
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects listed below are caused by the use of viagra . the following side effects may happen with viagra : an allergic reaction ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . chest pains may occur if you are in a semi - sitting position . you may be given nitrates to relieve your chest pain . prolonged and sometimes painful erections ( may occur up to a few days apart ) may occur ( may
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are marked with "
sifrol contains the active substance pramipexole and belongs to a group of medicines called dopamine agonists . dopamine receptors are receptors in the brain that help to control nerve impulses in thebrain . sifrol is used to treat the symptoms of primary parkinson ' s disease in adults . it is used in combination with levodopa to treat parkinson '. the symptoms are moderate to severe primary restless legs syndrome .
do not take sifrol if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sifol if you have any medical conditions or symptoms of kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are temporary . dyskinesia ( abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa may not be suitable for you . if you develop dyskineia , stop taking sufrol and talk to a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets per day . the first week of the first treatment dose is 1 tablet of sufrol 0 . 088 mg ( 0 . 264 mg ) per day , followed by 1 tablet in sifol 0 .088 mg ( 1 . 264 μg ) per week . your doctor may increase your dose if your symptoms return . the usual starting dose is two tablets per week , followed gradually by one tablet in the second week . the
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common ( might affect up to 1 in 100 people ) uncommon ( may affects up to1 in 1 , 000 people ) rare ( may effect up to one in 10 , 000 patients ) not known ( frequency cannot be estimated from the available data ) if you have parkinson ' s disease , tell your doctor straight away if you notice any of the following side effects : - dyskinesia ( abnormal , uncontrolled movements of the
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg , respectively ( 0 . 7 mg pramipxole in 0 . 125 mg , 1 mg pramanipexol in 0. 25 mg , and 0 . 5 mg pranimexole dihydrochloride monohydrate ). - the other ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what sifroll looks like and contents of the
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . allergic conditions can affect the way the eye works . the allergic reaction may be severe . allergic conjunctureivitis may occur in association with the use of some materials ( allergens ). allergic reactions may include itching , redness and swelling on the surface of your eye . if you notice any of these , tell your doctor immediately . if any of the reactions gets worse , tell the doctor straight away .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is more than 3 years old and has been exposed to benzalkonium chloride ( see section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before using emadin ). see section " warnings and risks " in section " other medicines and emadines " in this leaflet . children and adolescents do not give this medicine to children under the age of 6 years because it has not been studied in clinical trials . other medicines , em
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use adults use the recommended dose is 3 drops in each eye . use this tip only once a day . do not use this bottle on the eyes . children and adolescents use the same dose every day . adults use 3 drops per day . use in children and teenagers use in adults use in infants and children aged 1 year and above . use the emadine bottle with your hands . do this by gently squeezing the bottle . remove the cap . remove cap from snap collar
like all medicines , this medicine can cause side effects , although not everybody gets them . the effects of the drops are usually mild to moderate . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects in adults ( may effect up to1 in 100 people )effects in the back of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , cornealing staining and dry eye . general side effects : headache , difficulty sleeping , sinus headache , bad taste
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from light and infections . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emadine contains - the active substance is emadastine 0 . 5 mg / ml . - the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide ( for acidity levels and ph levels ). what emadINE looks like and contents of the pack emadrine is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiratam actavis is used in adults and adolescents from 16 years of age with newly diagnosed epilepsy . epilepsy is a form of epilepsy where the patients have repeated fits ( seizures ). leveiracetams is used for the epilepsy form in which the fits initially affect only one side of the brain but may thereafter extend to larger areas on both sides of the head ( partial onset seizure with or without secondary generalisation ). leetiracetamm has been given to you by your doctor to reduce the number of
do not take levetiracetam actavis - if you are allergic to leveturacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking levetiraacetamactavis - tell your doctor if you have kidney problems - tell the doctor if any slow down in the growth or puberty has been reported in patients taking anti - epileptics . levetiaracetam actsavis may cause thoughts of harming or killing themselves . tell your physician if you or your family or carer notices any symptoms
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . levetiracetam actavis is taken twice a day , once in the morning and once inthe evening . monotherapy dose in adults and adolescents 16 years of age and older : 1 , 000 mg twice a week ( total daily dose of 3 , 000 micrograms ) levetiraacetam actingavis is given as 2 tablets once a day ( total day dose of 1 , 500 microgram ) at the start of therapy dose in adolescents 17 years of years of ages
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed or dizzy or have difficulty breathing . these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms with a rash on the face and an extended rash with a high temperature . increased levels of liver enzymes seen in blood tests . reduction in a type of white blood cell ( 56 iu / kg ) ( e
what levetiracetam actavis contains the active substance is levetoracetam . levetaracetamactavis 250 mg : each tablet contains 250 mg of leveturacetam ( as levetyracetam ). levetieracetam actingavis 500 mg : one tablet contains 500 mg of the active ingredient levetiraacetam. leveteracetam actedavis 750 mg : every tablet contains 750 mg of of leveriraceta ( as besilate ). leveiracetarm actavis 1 , 000 mg : the active substances are : tablet core : crospovidon ,
the active substance umeclidinium bromide belongs to a group of bronchodilators . incruse ellipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in your lungs become blocked . this makes breathing difficulties difficult . incrose ellipte helps to stop this happening by preventing difficulties in breathing by tightening the muscles around the airway . this medicine helps to prevent tightening of these muscles in your airways and lungs . it also helps to control your breathing difficulties when you are being treated for copd . ellipt
do not use incruse ellipta 27 if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using incrusey ellipta : if you have asthma . incrusy ellipta may not be suitable for you if you suffer from asthma . if you smoke . if your doctor has told you that you have heart problems . if any of these apply to you , tell your doctor . if this applies to you . if if you think you have an eye problem called narrow - angle glaucoma
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours . you can use incruse ellipta at any time of the day . if you use more incruense ellipta than you should if you have used more incrose elliptas than you have been told to , contact your doctor straight away . symptoms of using too much of this medicine may include a sudden attack of breathlessness or wheezing . if this attack occurs
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are rare ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination a urinary tract infection common cold infection of nose throat cough feeling of pressure and pain in the cheeks and forehead inflammation of the sinuses ( sinusitis ) headache constipation uncommon side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhaler in the sealed tray in order to protect from light . after first opening of the inhalation , use within 6 months of first opening the inhalard . after opening the seal , use the inhalered within 30 . do away with the inhalER if you notice it is damaged or shows signs of tampering . medicines should not be
what incruse ellipta contains - the active substance is umeclidinium bromide . each inhalation provides a delivered dose of 55 micrograms umeklidinIUM ( equivalent to 65 microgram ) umecylidinum bromides . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemella contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incrusea ellipta is an inhalation powder . the ellipta inhaler is supplied in a grey plastic body with a light
what nucala is nucal contains the active substance mepolizumab , a monoclonal antibody . this is a type of protein that recognises and attaches to specific proteins in the body . what nucalan is used for nucale is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a type white blood cell that helps the airways to breathe ) and affects the lungs . in eosinsophilic asthma , the most common form of asthma nucalo is used in adults to help control asthma attacks .
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 if you experience asthma - related side effects , your doctor may decide to treat your asthma with nucal . if your asthma does not respond to nucalan treatment , your physician may decide not to treat you . if you think you may be allergic , ask your doctor for advice . injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg given once a week . the recommended starting dose is 1 ml . you can inject nucala yourself or in a clinic or a clinic . you should check with your doctor or pharmacist if you are not sure . how nucal is given your doctor will decide how much nucalo you need and will decide if the treatment is right for you . if you have any further questions on the use of nucale , ask your doctor , pharmacist or nurse . if your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) the injection may be given at the same time . sometimes symptoms may include symptoms such as chest tightness , cough , difficulty breathing fainting dizziness feeling lightheaded ( this may be due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you experience a reaction similar reaction to any of the following
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the nucalo pre -filled pen in the outer carton in order to protect from light . after first opening , the pen may be stored for up to 7 days in the refrigerator ( 4 8 ). discard the pre filled pen if it is not used within 7 days . do throw away any medicines via wastewater or
what nucala contains - the active substance is mepolizumab . each vial of 1 ml contains 100 mg of mepoluzumab ( as besilate ). - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucale is supplied as a 1 ml vial in a pack of 1 vials in a multipack of 3 vials of 1ml . not all pack sizes
what ninlaro is ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what ninlara is used for ninlare is used to treat a cancer of the bone marrow called multiple myeloma . ixezomib is used in cell survival to treat myelomas cells in which a lot of proteins called proteasomes have been destroyed . what ninlanaro is used on its own , the active ingredient in ninlero is lenalidomide and dexamethasone . what is multiple myelo ? multiple myelinoma is
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar if you : - have bleeding , persistent nausea , vomiting , diarrhoea , nerve problems , tingling , numbness , swelling or a persistent rash . - have liver or kidney problems . your doctor may decide to reduce the dose of treatment with ninlara . your dose may be reduced or stopped depending on how you respond to treatment . your blood tests will be taken to check that you have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule of dexamethasone ( an anti - inflammatory medicine ). your doctor will tell you how many capsules of ninlaro to take . the dose of lenalidomide and dexamthasone is divided into 4 - week courses . the first course of courses of courses is one dose of ninlio once a day on the same day of the week . the second course is one 4 - weekly course . the third course is two weeks of courses . your doctor may
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (' peripheral oedema ') skin rash that may become itchy all over the body rare side effects these may affect up to 1 in 1 , 000 people severe skin rashes , red to purple bumps (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the exp date refers to the last day of that month . do store above 30 . store in the original package in order to protect from moisture . once the capsule has been opened , use this medicinal product immediately . do away with any damage to the packaging . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains - the active substance of ninlar is ixazomib . each capsule contains 2 . 3 mg ixasomib ( corresponding to 3 . 3 micrograms ixabomib citrate ). - the other ingredients are microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide . what ninlara looks like and contents of the pack - the capsule is white to off - white ,
do not use palforzia if you are allergic to peanuts ( arachis hypogaea ) or any of the other ingredients of palforbzia ( listed in section 6 ). children and adolescents from 4 to 17 years of age should not receive treatment for peanut allergy . peanut ( desensitisation ) is not a substance present in food . palfiorzia is not intended to cause allergic reactions . pforzias is not indicated for the treatment of food allergies . if you have any further questions on the use of pfalforzeria , ask your doctor or pharmacist .
do not take palforzia if you are allergic to peanut or soya or any of the other ingredients of palforbzia ( listed in section 6 ). if your asthma is severe or has a problem swallowing . if you have long term problems with your digestive system . if your doctor has told you that you have a severe mast cell disorder . if this applies to you , tell your doctor . if severe or life - threatening anaphylaxis occurs within 60 days of treatment with your palforfzia . if any of these apply to you ( or you are not sure ), talk to your doctor or pharm
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . allergy if you have allergic reactions ( anaphylaxis ) to palforzia , contact your doctor . the recommended dose is 3 mg once daily . your doctor will decide how long you should continue treatment with palforfzia . initial doseescalation and up - dosing steps are given to you by your doctor as part of these treatment steps . the initial dose elevation and up dosing phases are given by your physician . if you take more palforbz
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with palforzia : severe allergic reactions if you have any of the following symptoms while taking palforfzia , stop taking the medicine and seek medical help immediately : trouble breathing , throat tightness , feeling offulness , trouble swallowing , speaking - changes in voice , dizziness or fainting severe stomach cramps , pain , vomiting , diarrhoea , severe flushing and itching of the skin palfORzia may cause problems with the stomach and digestive system ( eosinoph
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or if the seal is broken . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palfofen . each 0 . 5 mg / 1 mg / 10 mg / 20 mg oral powder in capsules with opening microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palforbzia 100 mg / 2 mg oralpowder in capsules without opening microstalline cellularose , Colloidal an hydrous silico and magnesium unstearate ppalforza 300 mg / 5 mg oral solution in sachet microcrystine celluloses , colloid anhydrated silica , magnesium stearingate pforz
zerne belongs to a group of substances called benzodiazepine - related medicinal products . hypnotic actions are used to treat sleeping problems . zerene is indicated for treatment of problems sleeping .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenea sleep apnoea syndrome ( short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( very weak , tired muscles , severe breathing and chest problems ). warnings and precautions talk to your doctor or pharmacist before taking zeren . undesirable effects if you take any medicine , including any medicines that increase physical dependence , during treatment , you may experience withdrawal symptoms such as headaches , muscle pain , extreme anxiety , tension ,
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg capsule per day . if you have difficulty falling asleep , you should take the capsule at least one hour before or one hour after your usual dose . if your doctor tells you to take the capsules at the same time each day , you can take the dose at the usual time . if this happens , you may take the medicine at the recommended time . do not take more than the recommended daily dose . do this if you notice that the capsule is cloudy or there are particles
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) uncommon : 1 to 5 users in 1 , 000 not known ( frequency cannot be estimated from the available data ) very rare ( affects less than 1 users in 10 , 000 ) very common ( affect less than one user in 100 ): not known : frequency cannot been estimated from available data . if
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( i171 ), gelatin , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , black iron oxide (< e172 ) and sodium laurel sulphacy ( e133 ), silicon dioxide . - printing ink : shellac , lecithin , simethicone , yellow
